Roy F. Chemaly, M.D., M.P.H., FACP, FIDSA

Peer-Reviewed Articles

1. Dioverti V, Boghdadly ZE, Shahid Z, Waghmare A, Abidi M, Pergam S, Boeckh M, Dadwal S, Kamboj M, Seo S, Chemaly RF, Papanicolaou GA.. Revised Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients. Transplant Cell Theory 22:S2666-6367, 2022. PMID: 36103987.
2. Hayase E, Hayase T, Jamal MA, Miyama T, Chang CC, Ortega MR, Ahmed SS, Karmouch JL, Sanchez CA, Brown AN, El-Himri RK, Flores II, McDaniel LK, Pham D, Halsey T, Frenk AC, Chapa VA, Heckel BE, Jin Y, Tsai WB, Prasad R, Tan L, Veillon L, Ajami NJ, Wargo JA, Galloway-Peña J, Shelburne S, Chemaly RF, Davey L, Glowacki RWP, Liu C, Rondon G, Alousi AM, Molldrem JJ, Champlin RE, Shpall EJ, Valdivia RH, Martens EC, Lorenzi PL, Jenq RR. Mucus-degrading Bacteroides link carbapenems to aggravated graft-versus-host disease. Cell 185(20):3705-3719.e14, 2022. PMID: 36179667.
3. Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García-García Á, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA, Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team, Kontoyiannis DP, Malek AE, Chaftari AM. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship. medRxiv, 2022. e-Pub 2022. PMID: 36097568.
4. El Haddad L, Angelidakis G, Clark JR, Mendoza JF, Terwilliger AL, Chaftari CP, Duna M, Yusuf ST, Harb CP, Stibich M, Maresso A, Chemaly RF. Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in the Galleria mellonella Wax Moth Larvae Model. Pharmaceutics 14(8):1591, 2022. e-Pub 2022. PMID: 36015218.
5. 161. Angelidakis G, Khawaja F, Mulanovich VE, Dailey Garnes N, Ariza Heredia E, Chemaly RF.. Combination of Baloxavir and Oseltamivir for Treatment of Severe Influenza Infection in Hematopoietic Cell Transplant Recipients: A Novel Treatment Strategy for a High-risk Population. Microbes Infect(104895), 2021.
6. Hakki M, Aitken SL, Danziger-Isakov L, Michaels MG, Carpenter PA, Chemaly RF, Papanicolaou GA, Boeckh M, Marty FM. American Society for Transplantation and Cellular Therapy Series: #3-Prevention of Cytomegalovirus Infection and Disease After Hematopoietic Cell Transplantation. Transplant Cell Ther 27(9):707-719, 2021. PMID: 34452721.
7. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Henke DM, Patel KD, Piedra FA, Angelo LS, Shah DP, Chemaly RF, Piedra PA. Humoral and Mucosal Antibody Response to RSV Structural Proteins in RSV-Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Viruses 13(6), 2021. e-Pub 2021. PMID: 34073490.
8. Chemaly RF, Marty FM, Wolfe CR, Lawrence SJ, Dadwal S, Soave R, Farthing J, Hawley S, Montanez P, Hwang J, Ho J, Lewis S, Wang G, Boeckh M. DAS181 Treatment of Severe Lower Respiratory Tract Parainfluenza Virus Infection in Immunocompromised Patients: A Phase 2 Randomized, Placebo-Controlled Study. Clin Infect Dis , 2021. e-Pub 2021. PMID: 33569576.
9. Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales MA, Seropian S, Shaw BE, Tuschl EE, Zeidan AM, Riches ML, Shah GL. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol(19:S2352-3026(20)30429), 2021. e-Pub 2021. PMID: 33482113.
10. Simmons SE, Carrion R, Alfson KJ, Staples HM, Jinadatha C, Jarvis WR, Sampathkumar P, Chemaly RF, Khawaja F, Povroznik M, Jackson S, Kaye KS, Rodriguez RM, Stibich MA. Deactivation of SARS-CoV-2 with pulsed-xenon ultraviolet light: Implications for environmental COVID-19 control. Infect Control Hosp Epidemiol 42(2):127-130, 2021. e-Pub 2020. PMID: 32741425.
11. Gans H, Chemaly RF. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program. BMC Infect Dis 21(1):46, 2021. e-Pub 2021. PMID: 33430796.
12. Avery RK, Alain S, Alexander BD, Blumberg EA, Chemaly RF, Cordonnier C, Duarte RF, Florescu DF, Kamar N, Kumar D, Maertens J, Marty FM, Papanicolaou GA, Silveira FP, Witzke O, Wu J, Sundberg AK, Fournier M. Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results from a Phase 3 Randomized Clinical Trial. Clin Infect Dis, 2021. PMID: 34864943.
13. Chemaly RF, Dadwal SS, Bergeron A, Ljungman P, Kim YJ, Cheng GS, Pipavath SN, Limaye AP, Blanchard E, Winston DJ, Stiff PJ, Zuckerman T, Lachance S, Rahav G, Small CB, Mullane KM, Patron RL, Lee DG, Hirsch HH, Waghmare A, McKevitt M, Jordan R, Guo Y, German P, Porter DP, Gossage DL, Watkins TR, Marty FM, Chien JW, Boeckh M. A phase 2, randomized, double-blind, placebo-controlled trial of presatovir for the treatment of respiratory syncytial virus upper respiratory tract infection in hematopoietic-cell transplant recipients. Clin Infect Dis 71(11):2777-2786, 2020. e-Pub 2019. PMID: 31793991.
14. Marty F, Chemaly RF, Mullane K, Lee DG, Hirsch HH, Small CB, Bergeron A, Sholam S, Ljungman P, Waghmare A. . A phase 2b, randomized, double-blind, placebo-controlled multicenter study evaluating antiviral effects, pharmacokinetics, safety, and tolerability of presatovir in hematopoietic cell transplant recipients with respiratory syncytial virus (RSV) infection of the lower respiratory tract. Clin Infect Dis, 2020. e-Pub 2019.
15. Chemaly RF, El Haddad L, Winston DJ, Rowley SD, Mulane KM, Chandrasekar P, Avery RK, Hari P, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad SB, Dadwal SS, Blanchard T, Shah DP, Jiang Y, Ariza-Heredia E. Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study. Clin Infect Dis 71(9):2365-2374, 2020. e-Pub 2020. PMID: 32076709.
16. Ariza-Heredia E, Frenzel E, Cantu S, Carlson M, Thomas G, Khawaja F, Raad II, Chemaly RF. Surveillance and Identification of Clusters of Health Care Workers with COVID-19: Multidimensional Interventions at a Comprehensive Cancer Center. Infect Control Hosp Epidemiol(1-21. e-Pub 11/2020. PMID: 33183368 PMCID: PMC7737142), 2020. e-Pub 2020. PMID: 33183368.
17. Simmons S, Carrion R, Alfson K, Staples H, Jinadatha C, Jarvis W, Sampathkumar P, Chemaly RF, Khawaja F, Povroznik M, Jackson S, Kaye KS, Rodriguez RM, Stibich M. Deactivation of SARS-CoV-2 with Pulsed Xenon Ultraviolet: implications for environmental COVID-19 control. Infect Control Hosp Epidemiol(2020 Aug 3:1-19), 2020.
18. Marty FM, Ljungman PT, Chemaly RF, Wan H, Teal VL, Butterton JR, Yeh WW, Leavitt RY, Badshah CS. Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. Am J Transplant 20(6):1703-1711, 2020. e-Pub 2020. PMID: 31883426.
19. Abudayyeh A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Martinez CS, Page VD, Tarrand JJ, Kontoyiannis DP, Marin D, Oran B, Olson A, Jones R, Popat U, Champlin RE, Chemaly RF, Shpall EJ, Rezvani K. Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients. Transpl Infect Dis(30:e13395), 2020.
20. Ye X, Cabral de Rezende W, Iwuchukwu OP, Avadhanula V, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (p27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Adult Hematopoietic Cell Transplant (HCT) Recipients. Vaccines (Basel)(8(2):192), 2020.
21. Maertens J, Logan AC, Jang J, Long G, Tang JL, Hwang WYK, Koh LP, Chemaly R, Gerbitz A, Winkler J, Yeh SP, Hiemenz J, Christoph S, Lee DG, Wang PN, Holler E, Mielke S, Akard L, Yeo A, Ramachandra S, Smith K, Pertel P, Segal F. Anti-human cytomegalovirus monoclonal antibodies for prophylaxis in hematopoietic cell transplantation: a phase 2 study. Antimicrob Agents Chemother 64(4), 2020. e-Pub 2020. PMID: 32015031.
22. Malek AE, Gutierrez C, Mulanovich VE, Botdorf J, Chemaly RF, Shah S, McCall BM, Melancon JT, McConn KK, Borjan J, Raad II, Burger JA, Garcia-Manero G, Adachi JA. Successful Outcomes of Severe COVID-19 in Patient with Chronic Lymphocytic Leukemia: Diagnostic Challenges in Immunocompromised Hosts. Mediterr J Hematol Infect Dis 12(1):e2020044, 2020. e-Pub 2020. PMID: 32670522.
23. Kmeid J, Kulkarni PA, Batista MV, El Chaer F, Prayag A, Ariza-Heredia EJ, Mulanovich VE, Chemaly RF. Active Mycobacterium tuberculosis infection at a comprehensive cancer center, 2006-2014. BMC Infect Dis 19(1):934, 2019. e-Pub 2019. PMID: 31694567.
24. Eleni Magira, Roy Chemaly, Ying Jiang, Jeffrey Tarrand, Dimitrios Kontoyiannis. Outcomes in Invasive Pulmonary Aspergillosis Infections Complicated by Respiratory Viral Infections in Patients with Hematologic Malignancies. Open Forum Infect Dis(2019 Jul 19:6 (7)), 2019.
25. Galloway-Peña JR, Peterson CB, Malik F, Sahasrabhojane PV, Shah DP, Brumlow CE, Carlin LG, Chemaly RF, Im JS, Rondon G, Felix E, Veillon L, Lorenzi PL, Alousi AM, Jenq RR, Kontoyiannis DP, Shpall EJ, Shelburne SA, Okhuysen PC. Fecal Microbiome, Metabolites, and Stem Cell Transplant Outcomes: A Single-Center Pilot Study. Open Forum Infect Dis 6(5):ofz173, 2019. e-Pub 2019. PMID: 31065565.
26. Kontoyiannis DP, Shah EC, Wurster S, Aitken SL, Graviss L, Raad II, Chemaly RF. Culture-Documented Invasive Mold Infections at MD Anderson Cancer Center in Houston, Texas, Pre- and Post-Hurricane Harvey. Open Forum Infect Dis 6(4):ofz138, 2019. e-Pub 2019. PMID: 31024975.
27. Kontoyiannis DP, Shah EC, Chemaly RF, Graviss L, Wurster S, Aitken SL. Culture-Documented invasive mold infections at MD Anderson Cancer Center Houston, Texas pre and post Hurricane Harvey, 2019.
28. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults. Front Immunol 10:706, 2019. e-Pub 2019. PMID: 30984206.
29. Sheshadri A, Godoy M, Erasmus JJ, Gruschkus S, Hasan A, Evans SE, Barreda-Garcia J, Chemaly RF, Dickey B, Ost D. Progression of the Radiologic Severity Index is associated with increased mortality and healthcare resource utilisation in acute leukaemia patients with pneumonia. BMJ Open Respir Res 6(1):e000471, 2019. e-Pub 2019. PMID: 31921429.
30. Ye X, Iwuchukwu OP, Avadhanula V, Aideyan LO, McBride TJ, Ferlic-Stark LL, Patel KD, Piedra FA, Shah DP, Chemaly RF, Piedra PA. Comparison of Palivizumab Like Antibody Binding to Different Conformations of the RSV F Protein in RSV Infected Adult Hematopoietic Cell Transplant Recipients. J Infect Dis 217(8):1247-1256, 2018. e-Pub 2018. PMID: 29365155.
31. Sheshadri A, Shah DP, Godoy M, Erasmus JJ, Song J, Li L, Evans SE, Chemaly RF, Dickey BF, Ost DE. Progression of the Radiologic Severity Index predicts mortality in patients with parainfluenza virus-associated lower respiratory infections. PLoS One 13(5):e0197418, 2018. e-Pub 2018. PMID: 29771962.
32. El Haddad L, Ghantoji SS, Stibich M, Fleming JB, Segal C, Ware KM, Chemaly RF. Evaluation of a pulsed xenon ultraviolet disinfection system to decrease bacterial contamination in operating rooms. BMC Infect Dis 17(1):672, 2017. e-Pub 2017. PMID: 29017457.
33. Liu X, Bian S, Zhang Y, Zhang L, Yang Q, Wang P, Xu Y, Shi X, Zhang Y, Chemaly RF. The characteristics of patients with mycobacterium tuberculosis blood stream infections in Beijing, China: a retrospective study. BMC Infect Dis 16(1):750, 2016. e-Pub 2016. PMID: 27955709.
34. Kimball LE, Stevens-Ayers T, Green ML, Xie H, Flowers ME, Jerome KR, LeBlanc R, Dahlgren C, Nichols WG, Chemaly RF, Papanicolaou G, Boeckh M. A MULTICENTER, LONGITUDINAL, INTERVENTIONAL, DOUBLE BLIND RANDOMIZED CLINICAL TRIAL IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS RESIDING IN REMOTE AREAS: LESSONS LEARNED FROM THE LATE CYTOMEGALOVIRUS PREVENTION TRIAL. Contemp Clin Trials Commun 4:84-89, 2016. e-Pub 2016. PMID: 28184381.
35. El-Haddad D, El Chaer F, Vanichanan J, Shah DP, Ariza-Heredia EJ, Mulanovich VE, Gulbis AM, Shpall EJ, Chemaly RF. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience. Antiviral Res 134:58-62, 2016. e-Pub 2016. PMID: 27582067.
36. Nesher L, Shah DP, Ariza-Heredia EJ, Azzi JM, Siddiqui HK, Ghantoji SS, Marsh LY, Michailidis L, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF. Utility of the Enzyme-Linked Immunospot Interferon-γ-Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients. J Infect Dis 213(11):1701-7, 2016. e-Pub 2016. PMID: 26908740.
37. Saunders IM, Lahoti A, Chemaly RF, Trevino C, Westmoreland M, Hosing C. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections. J Oncol Pharm Pract 22(2):325-31, 2016. e-Pub 2014. PMID: 25488905.
38. Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index. Biol Blood Marrow Transplant 22(3):542-8, 2016. e-Pub 2015. PMID: 26638804.
39. Shah DP, Shah PK, Azzi JM, Chemaly RF. Parainfluenza virus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett 370(2):358-64, 2016. e-Pub 2015. PMID: 26582658.
40. Chemaly RF, Ghantoji SS, Huber T, Raad II, Jinadatha C, Stibich M. Innovative Analysis of the Sequenced Patterns of Vancomycin-Resistant Enterococci Strains to Determine Clonal Transmission in a Hospital Setting. Infect Control Hosp Epidemiol 36(12):1-3, 2015. e-Pub 2015. PMID: 26329908.
41. Avadhanula V, Chemaly RF, Shah DP, Ghantoji SS, Azzi JM, Aideyan LO, Mei M, Piedra PA. Infection with Novel Respiratory Syncytial Virus Genotype Ontario (ON1) in Adult Hematopoietic Cell Transplant Recipients, Texas, 2011-2013. J Infect Dis 211(4):582-9, 2015. e-Pub 2014. PMID: 25156562.
42. Nesher L, Rolston KV, Shah DP, Tarrand JT, Mulanovich V, Ariza-Heredia EJ, Chemaly RF. Fecal colonization and infection with Pseudomonas aeruginosa in recipients of allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 17(1):1-6, 2015. e-Pub 2014. PMID: 25546740.
43. Ghantoji SS, Stibich M, Stachowiak J, Cantu S, Adachi JA, Raad II, Chemaly RF. Non-inferiority of pulsed xenon UV light versus bleach for reducing environmental Clostridium difficile contamination on high-touch surfaces in Clostridium difficile infection isolation rooms. J Med Microbiol 64(Pt 2):191-4, 2015. PMID: 25627208.
44. Chemaly RF, Dantes R, Shah DP, Shah PK, Pascoe N, Ariza-Heredia E, Perego C, Nguyen DB, Nguyen K, Modarai F, Moulton-Meissner H, Noble-Wang J, Tarrand JJ, LiPuma JJ, Guh AY, MacCannell T, Raad I, Mulanovich V. Cluster and Sporadic Cases of Herbaspirillum spp. Infections in Patients with Cancer. Clin Infect Dis 60(1):48-54, 2015. e-Pub 2014. PMID: 25216687.
45. Boeckh M, Nichols WG, Chemaly RF, Papanicolaou GA, Wingard JR, Xie H, Syrjala KL, Flowers ME, Stevens-Ayers T, Jerome KR, Leisenring W. Valganciclovir for the prevention of complications of late cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a randomized trial. Ann Intern Med 162(1):1-10, 2015. PMID: 25560711.
46. Ariza-Heredia EJ, Gulbis AM, Stolar KR, Kebriaei P, Shah DP, McConn KK, Champlin RE, Chemaly RF. Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice. Transpl Infect Dis 16(6):878-86, 2014. e-Pub 2014. PMID: 25405922.
47. Esmaily-Fard A, Tverdek FP, Crowther DM, Ghantoji SS, Adachi JA, Chemaly RF. The use of fidaxomicin for treatment of relapsed Clostridium difficile infections in patients with cancer. Pharmacotherapy 34(11):1220-5, 2014. e-Pub 2014. PMID: 25164587.
48. Nesher L, Chemaly RF, Shah DP, Mulanovich VE, Hosing C, Rolston KV. Utility of routine surveillance blood cultures in asymptomatic allogeneic hematopoietic stem cell transplant recipients with indwelling central venous catheters at a comprehensive cancer center. Am J Infect Control 42(10):1084-8, 2014. PMID: 25278398.
49. Chemaly RF, Ghantoji SS, Shah DP, Shah JN, El Taoum KK, Champlin RE, Nunez CA, Mulanovich V, Ariza-Heredia E. Respiratory Syncytial Virus Infections in Children with Cancer. J Pediatr Hematol Oncol 36(6):e376-81, 2014. PMID: 24327130.
50. Haynes AB, Bloom ES, Bedrosian I, Kuerer HM, Hwang RF, Munsell MF, Chemaly RF, Graviss LS, Caudle AS, Hunt KK, Tereffe W, Shaitelman SF, Babiera GV. Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation. Ann Surg Oncol 21(8):2512-6, 2014. e-Pub 2014. PMID: 24736987.
51. Chemaly RF, Ullmann AJ, Stoelben S, Richard MP, Bornhäuser M, Groth C, Einsele H, Silverman M, Mullane KM, Brown J, Nowak H, Kölling K, Stobernack HP, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Champlin RE, Ehninger G, AIC246 Study Team. Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 370(19):1781-9, 2014. PMID: 24806159.
52. Yilmaz M, Chemaly RF, Han XY, Thall PF, Fox PS, Tarrand JJ, De Lima MJ, Hosing CM, Popat UR, Shpall E, Champlin RE, Qazilbash MH. Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplant 48(9):1218-23, 2013. e-Pub 2013. PMID: 23503529.
53. Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Jiang Y, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF. Impact of aerosolized ribavirin on mortality in 280 allogeneic haematopoietic stem cell transplant recipients with respiratory syncytial virus infections. J Antimicrob Chemother 68(8):1872-80, 2013. e-Pub 2013. PMID: 23572228.
54. Mahale P, Kontoyiannis DP, Chemaly RF, Jiang Y, Hwang JP, Davila M, Torres HA. Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients. J Hepatol 57(6):1177-85, 2012. e-Pub 2012. PMID: 22871500.
55. Kamboj M, Son C, Cantu S, Chemaly RF, Dickman J, Dubberke E, Engles L, Lafferty T, Liddell G, Lesperance ME, Mangino JE, Martin S, Mayfield J, Mehta SA, O'Rourke S, Perego CS, Taplitz R, Eagan J, Sepkowitz KA. Hospital-Onset Clostridium difficile Infection Rates in Persons with Cancer or Hematopoietic Stem Cell Transplant: A C3IC Network Report. Infect Control Hosp Epidemiol 33(11):1162-5, 2012. e-Pub 2012. PMID: 23041818.
56. Chemaly RF, Torres HA, Munsell MF, Shah DP, Rathod DB, Bodey GP, Hosing C, Saifan C, Raad II, Champlin RE. An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection. J Infect Dis 206(9):1367-71, 2012. e-Pub 2012. PMID: 22927454.
57. Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza a (H1N1) infection in patients with solid tumors in 3 countries: Early therapy improves outcomes. Cancer 118(18):4627-33, 2012. e-Pub 2012. PMID: 22359314.
58. Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and Outcomes of Pandemic 2009/H1N1 versus Seasonal Influenza in Children with Cancer. Pediatr Infect Dis J 31(4):373-8, 2012. e-Pub 2012. PMID: 22228234.
59. Chemaly RF, Hanmod SS, Rathod DB, Ghantoji SS, Jiang Y, Doshi A, Vigil K, Adachi JA, Khoury AM, Tarrand J, Hosing C, Champlin R. The characteristics and outcomes of parainfluenza virus infections in 200 patients with leukemia or recipients of hematopoietic stem cell transplantation. Blood 119(12):2738-45; quiz 2969, 2012. e-Pub 2012. PMID: 22246027.
60. Anaya DA, Cormier JN, Xing Y, Koller P, Gaido L, Hadfield D, Chemaly RF, Feig BW. Development and Validation of a Novel Stratification Tool for Identifying Cancer Patients at Increased Risk of Surgical Site Infection. Ann Surg 255(1):134-9, 2012. e-Pub 2011. PMID: 22143206.
61. Mahajan SN, Shah JN, Hachem R, Tverdek F, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Patients with Cancer Treated with Vancomycin: 9-Year Experience at a Comprehensive Cancer Center. Oncologist 17(10):1329-36, 2012. e-Pub 2012. PMID: 22707509.
62. Raval M, Gulbis A, Bollard C, Leen A, Chemaly R, Shpall E, Lahoti A, Kebriaei P. Evaluation and Management of BK Virus-Associated Nephropathy Following Allogeneic Hematopoietic Cell Transplantation. Biol Blood Marrow Transplant 17(11):1589-93, 2011. e-Pub 2011. PMID: 21767514.
63. Campo M, Hachem R, Jiang Y, Dvorak T, Carrilo-Marquez M, Hulten K, Chemaly RF, Raad I. Panton Valentine Leukocidin Exotoxin Has No Effect on the Outcome of Cancer Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. Medicine (Baltimore) 90(5):312-8, 2011. e-Pub 2011. PMID: 21862937.
64. Chemaly RF, Rathod DB, Sikka MK, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Trenholme G, Raad I. Serratia marcescens bacteremia because of contaminated prefilled heparin and saline syringes: A multi-state report. Am J Infect Control 39(6):521-4, 2011. e-Pub 2011. PMID: 21492963.
65. Marty FM, Ljungman P, Papanicolaou GA, Winston DJ, Chemaly RF, Strasfeld L, Young JA, Rodriguez T, Maertens J, Schmitt M, Einsele H, Ferrant A, Lipton JH, Villano SA, Chen H, Boeckh M, Maribavir 1263-300 Clinical Study Group. Maribavir prophylaxis for prevention of cytomegalovirus disease in recipients of allogeneic stem-cell transplants: a phase 3, double-blind, placebo-controlled, randomised trial. Lancet Infect Dis 11(4):284-92, 2011. e-Pub 2011. PMID: 21414843.
66. Kassis C, Hachem R, Raad II, Perego CA, Dvorak T, Hulten KG, Frenzel E, Thomas G, Chemaly RF. Outbreak of community-acquired methicillin-resistant Staphylococcus aureus skin infections among health care workers in a cancer center. Am J Infect Control 39(2):112-7, 2011. e-Pub 2010. PMID: 20817317.
67. Stibich M, Stachowiak J, Tanner B, Berkheiser M, Moore L, Raad I, Chemaly RF. Evaluation of a pulsed-xenon ultraviolet room disinfection device for impact on hospital operations and microbial reduction. Infect Control Hosp Epidemiol 32(3):286-8, 2011. PMID: 21460515.
68. Ramos ER, Reitzel R, Jiang Y, Hachem RY, Chaftari AM, Chemaly RF, Hackett B, Pravinkumar SE, Nates J, Tarrand JJ, Raad II. Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience. Crit Care Med 39(2):245-51, 2011. e-Pub 2010. PMID: 21057308.
69. Chemaly RF, Sharma PS, Youssef S, Gerber D, Hwu P, Hanmod SS, Jiang Y, Hachem RY, Raad II. The Efficacy of Catheters Coated with Minocycline and Rifampin in the Prevention of Catheter Related Bacteremia in Cancer Patients receiving High Dose Interleukin-2. Int J Infect Dis 14(7):e548-52, 2010. e-Pub 2009. PMID: 20005762.
70. Safdar A, Rodriguez GH, Mihu CN, Mora-Ramos L, Mulanovich V, Chemaly RF, Champlin RE, Khouri I. Infections in Nonmyeloablative Hematopoietic Stem Cell Transplantation Patients with Lymphoid Malignancies: Spectrum of Infections, Predictors of Outcome, and Proposed Guidelines for Fungal Infection Prevention. Bone Marrow Transplant 45(2):339-47, 2010. e-Pub 2009. PMID: 19561648.
71. Chemaly RF, Hachem RY, Husni RN, Bahna B, Abou Rjaili G, Waked A, Graviss L, Nebiyou Bekele B, Shah JN, Raad II. Characteristics and Outcomes of Methicillin-Resistant Staphylococcus aureus Surgical-Site Infections in Patients with Cancer: a Case-Control Study. Ann Surg Oncol 17(6):1499-506, 2010. e-Pub 2010. PMID: 20127184.
72. Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents 36(2):182-6, 2010. e-Pub 2010. PMID: 20452752.
73. Kassis C, Champlin RE, Hachem RY, Hosing C, Tarrand JJ, Perego CA, Neumann JL, Raad II, Chemaly RF. Detection and Control of a Nosocomial Respiratory Syncytial Virus Outbreak in a Stem Cell Transplantation Unit: The Role of Palivizumab. Biol Blood Marrow Transplant 16(9):1265-71, 2010. e-Pub 2010. PMID: 20304082.
74. Blossom D, Noble-Wang J, Su J, Pur S, Chemaly R, Shams A, Jensen B, Pascoe N, Gullion J, Casey E, Hayden M, Arduino M, Budnitz DS, Raad I, Trenholme G, Srinivasan A. Multistate outbreak of Serratia marcescens bloodstream infections caused by contamination of prefilled heparin and isotonic sodium chloride solution syringes. Arch Intern Med 169(18):1705-11, 2009. PMID: 19822828.
75. Adachi JA, Perego C, Graviss L, Dvorak T, Hachem R, Chemaly RF, Raad II. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients. Am J Infect Control 37(6):442-6, 2009. e-Pub 2008. PMID: 19118923.
76. Chemaly RF, Hanmod SS, Jiang Y, Rathod DB, Mulanovich V, Adachi JA, Rolston KV, Raad II, Hachem RY. Tigecycline use in cancer patients with serious infections: a report on 110 cases from a single institution. Medicine (Baltimore) 88(4):211-20, 2009. PMID: 19593226.
77. Vigil KJ, Mulanovich VE, Chemaly RF, Tarrand J, Raad II, Adachi JA. Severe parainfluenza virus type 2 supraglottitis in an immunocompetent adult host: an unusual cause of a paramyxoviridae viral infection. J Intern Med 265(3):397-400, 2009. PMID: 19019183.
78. Aisenberg G, Torres H, Tarrand J, Safdar A, Bodey G, Chemaly RF. Herpes Simplex Virus Lower Respiratory Tract Infection in Patients with Solid Tumors. Cancer 115(1):199-206, 2009. PMID: 19090003.
79. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 47(1):129-33, 2009. e-Pub 2008.
80. Vigil KJ, Adachi JA, Aboufaycal H, Hachem RY, Reitzel RA, Jiang Y, Tarrand JJ, Chemaly RF, Bodey GP, Rolston KV, Raad I. Multidrug-resistant Escherichia coli bacteremia in cancer patients. Am J Infect Control 37(9):741-5, 2009. PMID: 19487050.
81. Torres HA, Aguilera E, Safdar A, Rohatgi N, Raad II, Sepulveda C, Luna M, Kontoyiannis DP, Chemaly RF. Fatal cytomegalovirus pneumonia in patients with haematological malignancies: an autopsy-based case-control study. Clin Microbiol Infect 14(12):1160-6, 2008. PMID: 19046167.
82. Ghanem G, Hachem RY, Chemaly RF, Dvorak T, Hulten K, Graviss L, Raad II. The role of molecular methods in the prevention of nosocomial methicillin-resistant Staphylococcus aureus clusters in cancer patients. Am J Infect Control 36(9):656-60, 2008. PMID: 18834742.
83. Raad I, Reitzel R, Jiang Y, Chemaly RF, Dvorak T, Hachem R. Anti-adherence Activity and Antimicrobial Durability of Anti-infective-Coated Catheters Against Multidrug-Resistant Bacteria. J Antimicrob Chemother 62(4):746-50, 2008. PMID: 18653489.
84. Winston DJ, Young JA, Pullarkat V, Papanicolaou GA, Vij R, Vance E, Alangaden GJ, Chemaly RF, Petersen F, Chao N, Klein J, Sprague K, Villano SA, Boeckh M. Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem-cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study. Blood 111(11):5403-10, 2008. PMID: 18285548.
85. Lamaris GA, Esmaeli B, Chamilos G, Desai A, Chemaly RF, Raad II, Safdar A, Lewis RE, Kontoyiannis DP. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 27(5):343-7, 2008. PMID: 18183439.
86. Youssef S, Hachem R, Chemaly RF, Adachi J, Ying J, Rolston K, Raad I. The role of vitamin B6 in the prevention of haematological toxic effects of linezolid in patients with cancer. J Antimicrob Chemother 61(2):421-4, 2008. PMID: 18174198.
87. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II. Human herpesvirus-6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica 93(1):157-8, 2008. PMID: 18166808.
88. Safdar A, Rodriguez GH, De Lima MJ, Petropoulos D, Chemaly RF, Worth LL, Shpall EJ, Rolston KV, Raad II, Chan KW, Champlin RE. Infections in 100 cord blood transplantations: spectrum of early and late post transplant infections in adult and pediatric patients 1996-2005. Medicine (Baltimore) 86(6):324-33, 2007. PMID: 18004177.
89. Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I. Outcomes for and Risk Factors Associated with Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant Enterococcus faecium Bacteremia in Cancer Patients. Infect Control Hosp Epidemiol 28(9):1054-1059, 2007. PMID: 17932826.
90. Sims CR, Thompson K, Chemaly RF, Shpall EJ, Champlin RE, Safdar A. Oral topical cidofovir: novel route of drug delivery in a severely immunosuppressed patient with refractory multidrug-resistant herpes simplex virus infection. Transpl Infect Dis 9(3):256-9, 2007. PMID: 17605730.
91. Chamilos G, Luna M, Lewis RE, Chemaly R, Raad II, Kontoyiannis DP. Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: a retrospective, nonrandomized autopsy study. Clin Ther 29(9):1980-6, 2007. PMID: 18035197.
92. Lee LD, Berkheiser M, Jiang Y, Hackett B, Hachem RY, Chemaly RF, Raad II. Risk of bioaerosol contamination with Aspergillus species before and after cleaning in rooms filtered with high-efficiency particulate air filters that house patients with hematologic malignancy. Infect Control Hosp Epidemiol 28(9):1066-1070, 2007. PMID: 17932828.
93. Hachem RY, Chemaly RF, Ahmar CA, Jiang Y, Boktour MR, Rjaili GA, Bodey GP, Raad II. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. Antimicrob Agents Chemother 51(6):1905-11, 2007. PMID: 17387153.
94. Chemaly RF, Torres HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Safdar A, Raad II. Neuraminidase inhibitors improve outcome of patients with leukemia and influenza: an observational study. Clin Infect Dis 44(7):964-7, 2007. PMID: 17342649.
95. Ozdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M, Khouri IF, Hosing C, Kornblau SM, Anderlini P, Shpall EJ, Qazilbash MH, Molldrem JJ, Chemaly RF, Komanduri KV. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplant 40(2):125-136, 2007. e-Pub 2007. PMID: 17530009.
96. Torres HA, Aguilera EA, Mattiuzzi GN, Cabanillas ME, Rohatgi N, Sepulveda CA, Kantarjian HM, Jiang Y, Safdar A, Raad II, Chemaly RF. Characteristics and Outcome of Respiratory syncytial virus infection in patients with leukemia. Haematologica 92(9):1216-1223, 2007. PMID: 17666367.
97. Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, Jiang Y, Chemaly RF, Rolston K. Sources and Outcome of Bloodstream Infections in Cancer Patients: The Role of Central Venous Catheters. Eur J Clin Microbiol Infect Dis 26(8):549-56, 2007. PMID: 17582536.
98. Kumashi PR, Safdar A, Chamilos G, Chemaly RF, Raad II, Kontoyiannis DP. Fungal osteoarticular infections in patients treated at a comprehensive cancer center: a 10-year retrospective review. Clin Microbiol Infect 12(7):621-6, 2006. PMID: 16774557.
99. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91(7):986-9, 2006. PMID: 16757415.
100. Torres HA, Chemaly RF, Storey R, Aguilera EA, Nogueras GM, Safdar A, Rolston KV, Raad II, Kontoyiannis DP. Influence of type of cancer and hematopoietic stem cell transplantation on clinical presentation of Pneumocystis jiroveci pneumonia in cancer patients. Eur J Clin Microbiol Infect Dis 25(6):382-8, 2006. PMID: 16767486.
101. Torres HA, Kontoyiannis DP, Aguilera EA, Younes A, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Cytomegalovirus infection in patients with lymphoma: an important cause of morbidity and mortality. Clin Lymphoma Myeloma 6(5):393-8, 2006. PMID: 16640816.
102. Torres HA, Hanna HA, Graviss L, Chaiban G, Hachem R, Chemaly RF, Girgawy E, Raad II. Chest tube-related empyema due to methicillin-resistant Staphylococcus aureus: could the chest tube be coated with antiseptics?. Infect Control Hosp Epidemiol 27(2):195-7, 2006. PMID: 16465639.
103. Chemaly, RF, Gosh S, Bodey GP, et al. Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients A Retrospective Study at a Major Cancer Center. Medicine (Baltimore) 85(5):278-287, 2006.
104. Torres H, Hanna H, Graviss L, Hachem R, Chemaly RF, et al. Chest-tube-related methicillin-resistant Staphylococcus aureus empyema: Could the chest tube be coated with antiseptics?. Infection Control and Hospital Epidemiology 27:195-7, 2006.
105. Yusuf SW, Ali SS, Swafford J, Durand JB, Bodey GP, Chemaly RF, Kontoyiannis DP, Tarrand J, Rolston KV, Yeh ET, Raad II, and Safdar A. Culture-Positive and Culture-Negative Endocarditis in Patients with Cancer: A Retrospective Observational Study (1994-2004). Medicine (Baltimore) 85(2):86-94, 2006. PMID: 16609347.
106. Aisenberg GM, Jacobson K, Chemaly RF, Rolston KV, Raad II, Safdar A. Extrapulmonary tuberculosis active infection misdiagnosed as cancer: Mycobacterium tuberculosis disease in patients at a Comprehensive Cancer Center (2001-2005). Cancer 104(12):2882-7, 2005. PMID: 16245341.
107. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 5(12):775-85, 2005. PMID: 16310149.
108. Torres HA, Kontoyiannis DP, Bodey GP, Adachi JA, Luna MA, Tarrand JJ, Nogueras GM, Raad II, Chemaly RF. Gastrointestinal cytomegalovirus disease in patients with cancer: a two decade experience in a tertiary care cancer center. Eur J Cancer 41(15):2268-79, 2005. PMID: 16143517.
109. Chemaly RF, Yen-Lieberman B, Chapman J, et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. Am J Transplant 5(3):544-8, 2005. PMID: 15707409.
110. Chemaly RF, Torres HA, Hachem RY, et al. Cytomegalovirus pneumonia in patients with lymphoma. Cancer 104(6):1213-20, 2005. PMID: 16078263.
111. Chemaly RF, Yen-Lieberman B, Castilla EA, Reilly A, Arrigain S, Farver C, Avery RK, Gordon SM, Procop GW. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry. J Clin Microbiol 42(5):2168-72, 2004. PMID: 15131185.
112. Safdar A, Chemaly RF, Perego CA, Gonzalez VR, Rolston KV, Raad,, II, Tarrand JJ, Callender DL. Hospitalization of an oncology patient suspected of having severe acute respiratory syndrome: a setup for an infection control quagmire at a comprehensive cancer center. Cancer 98(12):2738-9, 2003. PMID: 14669300.
113. Chemaly RF, Yen-Lieberman B, Schindler SA, Goldfarb J, Hall GS, Procop GW. Rotaviral and bacterial gastroenteritis in children during winter: an evaluation of physician ordering patterns. J Clin Virol 28(1):44-50, 2003. PMID: 12927750.
114. Chemaly RF, Hall GS, Keys TF, Procop GW. Microbiology of liver abscesses and the predictive value of abscess gram stain and associated blood cultures. Diagn Microbiol Infect Dis 46(4):245-8, 2003. PMID: 12944014.
115. Hicks KL, Chemaly RF, Kontoyiannis DP. Common community respiratory viruses in patients with cancer: more than just "common colds". Cancer 97(10):2576-87, 2003. PMID: 12733157.
116. Liu W, Chemaly RF, Tuohy MJ, LaSalvia MM, Procop GW. Pasteurella multocida urinary tract infection with molecular evidence of zoonotic transmission. Clin Infect Dis 36(4):E58-60, 2003. PMID: 12567321.
117. Gumbo T, Chemaly RF, Isada CM, Hall GS, Gordon SM. Late complications of Candida (Torulopsis) glabrata fungemia: description of a phenomenon. Scand J Infect Dis 34(11):817-8, 2002. PMID: 12578150.
118. Chemaly RF, de Parres JB, Rehm SJ, Adal KA, Lisgaris MV, Katz-Scott DS, Curtas S, Gordon SM, Steiger E, Olin J, Longworth DL. Venous thrombosis associated with peripherally inserted central catheters: a retrospective analysis of the Cleveland Clinic experience. Clin Infect Dis 34(9):1179-83, 2002. PMID: 11941543.
119. Chemaly RF, Fox SB, Alkotob LM, Scharpf J, Sobecks R, Eliachar I, Procop GW, Smith M, Avery RK, Schmitt SK. A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient. Scand J Infect Dis 34(2):149-51, 2002. PMID: 11928855.
120. Chemaly RF, Rehm SJ. A young woman with fever, headache, and lymphadenopathy. Cleve Clin J Med 68(7):584, 586-7, 591-93, 2001. PMID: 11453074.
121. Chemaly RF, Tomford JW, Hall GS, Sholtis M, Chua JD, Procop GW. Rapid diagnosis of Histoplasma capsulatum endocarditis using the AccuProbe on an excised valve. J Clin Microbiol 39(7):2640-1, 2001. PMID: 11427583.
122. Shah DP, Ghantoji SS, Ariza-Heredia EJ, Shah JN, El Taoum KK, Shah PK, Nesher L, Hosing C, Rondon G, Champlin RE, Chemaly RF. An Immunodeficiency Scoring Index to predict poor outcomes in hematopoietic cell transplant recipients with respiratory syncytial virus infections. Blood. e-Pub 2014. PMID: 24700783.
123. Torres HA, Rallapalli V, Saxena A, Granwehr BP, Viola GM, Ariza-Heredia E, Adachi JA, Chemaly RF, Marfatia R, Jiang Y, Mahale P, Kyvernitakis A, Fanale MA, Mulanovich V. Efficacy and Safety of Antiretrovirals in HIV-Infected Patients with Cancer. Clin Microbiol Infect. e-Pub 2014. PMID: 24529214.
124. Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative Antimicrobial Prophylaxis for Intra-abdominal Surgery in Patients with Cancer: A Retrospective Study Comparing Ertapenem and Nonertapenem Antibiotics. Ann Surg Oncol. e-Pub 2013. PMID: 24114052.
125. Wilhelm K, Chemaly R, Saliba R, Gulbis A, Saunders I, Cool R, Ferguson J, Westmoreland M, Rondon G, Kebriaei P. The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation. J Oncol Pharm Pract. e-Pub 2013. PMID: 24022408.
126. Abudayyeh A, Hamdi A, Lin H, Abdelrahim M, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Osama Gaber A, Salahudeen A, Oran B, Chemaly RF, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Winkelmayer WC, Rezvani K. Symptomatic BK Virus Infection Is Associated with Kidney Function Decline and Poor Overall Survival in Allogeneic Hematopoietic Stem Cell Recipients. Am J Transplant. e-Pub 2015. PMID: 26608093.
127. Aitken SL, Zhou J, Ghantoji SS, Kontoyiannis DP, Jones RB, Tam VH, Chemaly RF. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients. J Antimicrob Chemother. e-Pub 2015. PMID: 26612873.
128. Ariza-Heredia EJ, Azzi J, Shah DP, Nesher L, Ghantoji SS, Michailidis L, Marsh L, Chemaly RF. Influenza Vaccination in Patients With Cancer: Factors Associated With Vaccination Practices for Patients and Their Household Members. Infect Control Hosp Epidemiol:1-3. e-Pub 2015. PMID: 26132392.
129. Nesher L, Tverdek FP, Mahajan SN, Chemaly RF, Rolston KV. Ertapenem usage in cancer patients with and without neutropenia: a report on 97 cases from a comprehensive cancer center. Infection. e-Pub 2015. PMID: 25929421.
130. Saliba RM, Rezvani K, Leen A, Jorgensen J, Shah N, Hosing C, Parmar S, Oran B, Olson A, Rondon G, Chen J, Martinez C, Hamdi A, Mehta RS, Chemaly R, Saunders IM, Bollard CM, Shpall EJ. General and Virus-Specific Immune Cell Reconstitution after Double Cord Blood Transplantation. Biol Blood Marrow Transplant. e-Pub 2015. PMID: 25708219.
131. Abudayyeh A, Hamdi A, Abdelrahim M, Lin H, Page VD, Rondon G, Andersson BS, Afrough A, Martinez CS, Tarrand JJ, Kontoyiannis DP, Marin D, Gaber AO, Oran B, Chemaly RF, Ahmed S, Abudayyeh I, Olson A, Jones R, Popat U, Champlin RE, Shpall EJ, Rezvani K. Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipients. Transpl Infect Dis. e-Pub 2016. PMID: 27862740.
132. Nesher L, Tarrand J, Chemaly RF, Rolston KV. Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center. Support Care Cancer. e-Pub 2016. PMID: 27885468.
133. El Chaer F, Mori N, Shah D, Oliver N, Wang E, Jan A, Doan V, Tverdek F, Tayar J, Ariza-Heredia E, Chemaly RF. Adjuvant and salvage therapy with leflunomide for recalcitrant cytomegalovirus infections in hematopoietic cell transplantation recipients: A case series. Antiviral Res 135:91-96. e-Pub 2016. PMID: 27594527.
134. Langman LJ, Nesher L, Shah DP, Azzi JM, Shpall EJ, Rezvani K, Black JL, Chemaly RF. Challenges in Determining Genotypes for Pharmacogenetics in Allogeneic Hematopoietic Cell Transplant Recipients. J Mol Diagn. e-Pub 2016. PMID: 27371869.
135. Aitken SL, Tarrand JJ, Deshpande LM, Tverdek FP, Jones AL, Shelburne SA, Prince RA, Bhatti MM, Rolston KV, Jones RN, Castanheira M, Chemaly RF. High rates of non-susceptibility to ceftazidime-avibactam and identification of New Delhi metallo-β-lactamase production in Enterobacteriaceae bloodstream infections at a major cancer center. Clin Infect Dis. e-Pub 2016. PMID: 27313265.
136. Galloway-Peña JR, Smith DP, Sahasrabhojane P, Ajami NJ, Wadsworth WD, Daver NG, Chemaly RF, Marsh L, Ghantoji SS, Pemmaraju N, Garcia-Manero G, Rezvani K, Alousi AM, Wargo JA, Shpall EJ, Futreal PA, Guindani M, Petrosino JF, Kontoyiannis DP, Shelburne SA. The role of the gastrointestinal microbiome in infectious complications during induction chemotherapy for acute myeloid leukemia. Cancer. e-Pub 2016. PMID: 27142181.
137. Frenzel E, Chemaly RF, Ariza-Heredia E, Jiang Y, Shah DP, Thomas G, Graviss L, Raad I. Association of increased influenza vaccination in health care workers with a reduction in nosocomial influenza infections in cancer patients. Am J Infect Control. e-Pub 2016. PMID: 27158088.
138. Sheshadri A, Chemaly RF, Alousi AM, Shah PK, Rondon G, Bashoura L, Kmeid J, Azzi J, Blanco DW, Kaous M, Dickey BF, Champlin RE, Shah DP. Pulmonary impairment following respiratory viral infections is associated with high mortality in allogeneic hematopoietic cell transplant recipients. Biol Blood Marrow Transplant. e-Pub 2018. PMID: 30521974.
139. El Haddad L, Ariza-Heredia E, Shah DP, Jiang Y, Blanchard T, Ghantoji SS, El Chaer F, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall E, Chemaly RF. The Ability of a Cytomegalovirus ELISPOT Assay to Predict Outcome of Low-Level CMV Reactivation in Hematopoietic Cell Transplant Recipients. J Infect Dis. e-Pub 2018. PMID: 30295846.
140. Marty FM, Winston DJ, Chemaly RF, Mullane KM, Shore TB, Papanicolaou GA, Chittick G, Brundage TM, Wilson C, Morrison ME, Foster SA, Nichols WG, Boeckh MJ, SUPPRESS Trial Clinical Study Group. A randomized, double-blind, placebo-controlled phase 3 trial of oral brincidofovir for cytomegalovirus prophylaxis in allogeneic hematopoietic-cell transplantation. Biol Blood Marrow Transplant. e-Pub 2018. PMID: 30292744.
141. Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF. Oral versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplantation Recipients. Clin Infect Dis. e-Pub 2018. PMID: 30202920.
142. Vakil E, Sheshadri A, Faiz SA, Shah DP, Zhu Y, Li L, Kmeid J, Azzi J, Balagani A, Bashoura L, Ariza-Heredia E, Chemaly RF. Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies. Transpl Infect Dis:e12994. e-Pub 2018. PMID: 30195271.
143. Azzi JM, Kyvernitakis A, Shah DP, El Haddad L, Mahajan SN, Ghantoji SS, Heredia-Ariza E, Chemaly RF. Leukopenia and lack of ribavirin predict poor outcomes in patients with haematological malignancies and respiratory syncytial virus infection. J Antimicrob Chemother. e-Pub 2018. PMID: 30113677.
144. Ariza-Heredia EJ, Chemaly RF, Shahani LR, Jang Y, Champlin RE, Mulanovich VE. Delay of alternative antiviral therapy and poor outcomes of acyclovir-resistant herpes simplex virus infections in recipients of allogeneic stem cell transplant - a retrospective study. Transpl Int. e-Pub 2018. PMID: 29464765.
145. Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation. N Engl J Med. e-Pub 2017. PMID: 29211658.
146. Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, Cogdill AP, Zhao L, Hudgens CW, Hutchinson DS, Manzo T, Petaccia de Macedo M, Cotechini T, Kumar T, Chen WS, Reddy SM, Sloane RS, Galloway-Pena J, Jiang H, Chen PL, Shpall EJ, Rezvani K, Alousi AM, Chemaly RF, Shelburne S, Vence LM, Okhuysen PC, Jensen VB, Swennes AG, McAllister F, Sanchez EMR, Zhang Y, Le Chatelier E, Zitvogel L, Pons N, Austin-Breneman JL, Haydu LE, Burton EM, Gardner JM, Sirmans E, Hu J, Lazar AJ, Tsujikawa T, Diab A, Tawbi H, Glitza IC, Hwu WJ, Patel SP, Woodman SE, Amaria RN, Davies MA, Gershenwald JE, Hwu P, Lee JE, Zhang J, Coussens LM, Cooper ZA, Futreal PA, Daniel CR, Ajami NJ, Petrosino JF, Tetzlaff MT, Sharma P, Allison JP, Jenq RR, Wargo JA. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. e-Pub 2017. PMID: 29097493.
147. Hammerstrom AE, Lombardi LR, Pingali SR, Rondon G, Chen J, Milton DR, Chemaly RF, Champlin RE, Gulbis A, Ciurea SO. Prevention of CMV Reactivation in Haploidentical Stem Cell Transplantation. Biol Blood Marrow Transplant. e-Pub 2017. PMID: 28986189.
148. Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, Chemaly RF. Influenza in Patients with Hematological Malignancies: Experience at Two Comprehensive Cancer Centers. J Med Virol. e-Pub 2017. PMID: 28851056.
149. El Chaer F, Shah DP, Kmeid J, Ariza-Heredia EJ, Hosing CM, Mulanovich VE, Chemaly RF. Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes. Cancer. e-Pub 2017. PMID: 28178369.
150. Grimley MS, Chemaly RF, Englund JA, Kurtzberg J, Chittick G, Brundage TM, Bae A, Morrison ME, Prasad VK. Brincidofovir for Asymptomatic Adenovirus Viremia in Pediatric and Adult Allogeneic Hematopoietic Cell Transplant Recipients: A Randomized Placebo-Controlled Phase II Trial. Biol Blood Marrow Transplant. e-Pub 2017. PMID: 28063938.
151. Ghobadi A, Milton DR, Gowda L, Rondon G, Chemaly RF, Hamdi A, Alousi A, Afrough A, Oran B, Ciurea S, Kebriaei P, Popat UR, Qazilbash MH, Shpall EJ, Champlin RE, Bashir Q. HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant. Curr Res Transl Med. e-Pub 2019. PMID: 30683577.
152. Fuentes S, Hahn M, Chilcote K, Chemaly RF, Shah DP, Ye X, Avadhanula V, Piedra PA, Golding H, Khurana S. Antigenic fingerprinting of RSV-A infected hematopoietic cell transplant recipients reveals importance of mucosal anti-RSV-G antibodies in control of RSV infection in humans. J Infect Dis. e-Pub 2019. PMID: 31745552.
153. El Haddad L, Ghantoji SS, Park AK, Batista M, Schelfhout J, Hachem J, Lobo Y, Jiang Y, Rondon G, Champlin R, Chemaly RF. Clinical and Economic Burden of Pre-emptive Therapy of Cytomegalovirus Infection in Hospitalized Allogeneic Hematopoietic Cell Transplant Recipients. J Med Virol. e-Pub 2019. PMID: 31448830.
154. Narula N, Lillemoe HA, Caudle AS, Chemaly RF, Anderson JJ, Segal C, Porter CA, Swisher SG, Levenback CF, Aloia TA. Postoperative Urinary Tract Infection Quality Assessment and Improvement: The S.T.O.P. UTI Program and Its Impact on Hospitalwide CAUTI Rates. Jt Comm J Qual Patient Saf. e-Pub 2019. PMID: 31371099.
155. Ljungman P, Schmitt M, Marty FM, Maertens J, Chemaly RF, Kartsonis NA, Butterton JR, Wan H, Teal VL, Sarratt K, Murata Y, Leavitt RY, Badshah C. A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation. Clin Infect Dis. e-Pub 2019. PMID: 31179485.
156. Sheshadri A, Karimipour M, Vakil E, Bashoura L, Godoy M, Arain MH, Evans SE, Dickey BF, Ost DE, Chemaly RF, Faiz SA. Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection. Transpl Infect Dis:e13105. e-Pub 2019. PMID: 31081570.
157. El Haddad L, Hanson BM, Arias CA, Ghantoji SS, Harb CP, Stibich M, Chemaly RF. Emergence and Transmission of Daptomycin and Vancomycin-Resistant Enterococci Between Patients and Hospital Rooms. Clin Infect Dis. e-Pub 2021. PMID: 33421068.
158. Alsumali A, Chemaly RF, Graham J, Jiang Y, Merchant S, Miles L, Schelfhout J, Yang J, Tang Y. Cost-Effectiveness Analysis of Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients from a US Payer Perspective. J Med Virol. e-Pub 2020. PMID: 32844453.
159. Cabrera NL, Malek AE, Shelburne S, Taremi M, Awadh H, Francisco D, Robins A, Jabbour E, Chemaly RF. Disseminated cytomegalovirus infection with bilateral adrenal pseudotumors masquerading as recurrent hematologic malignancy. Infection. e-Pub 2020. PMID: 32144592.
160. Yong MK, Shigle TL, Kim YJ, Carpenter PA, Chemaly RF, Papanicolaou GA. American Society of Transplantation and Cellular Therapy Series: #4 - Cytomegalovirus treatment and management of resistant or refractory infections after hematopoietic cell transplantation. Transplant Cell Ther. e-Pub 2021. PMID: 34560310.
161. Mulroney CM, Bilal Abid M, Bashey A, Chemaly RF, Ciurea SO, Chen M, Dandoy CE, Diaz Perez MA, Friend BD, Fuchs E, Ganguly S, Goldsmith SR, Kanakry CG, Kim S, Komanduri KV, Krem MM, Lazarus HM, Ljungman P, Maziarz R, Nishihori T, Patel SS, Perales MA, Romee R, Singh AK, Reid Wingard J, Yared J, Riches M, Taplitz R. Incidence and impact of community respiratory viral infections in post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis and haploidentical stem cell transplantation. Br J Haematol. e-Pub 2021. PMID: 34124796.
162. Olson A, Lin R, Marin D, Rafei H, Bdaiwi MH, Thall PF, Basar R, Abudayyeh A, Banerjee P, Aung FM, Kaur I, Abueg G, Rao S, Chemaly R, Mulanovich V, Al-Atrash G, Alousi AM, Andersson BS, Anderlini P, Bashir Q, Castro KM, Daher M, Galvan IM, Hosing C, Im JS, Jones RB, Kebriaei P, Khouri I, Mehta R, Molldrem J, Nieto Y, Oran B, Popat U, Qazilbash M, Rondon G, Saini N, Spencer B, Srour S, Washington D, Barnett M, Champlin RE, Shpall EJ, Rezvani K. Third-Party BK Virus-Specific Cytotoxic T Lymphocyte Therapy for Hemorrhagic Cystitis Following Allotransplantation. J Clin Oncol:JCO2002608. e-Pub 2021. PMID: 33929874.
163. Sassine J, Khawaja F, Shigle TL, Handy V, Foolad F, Aitken S, Jiang Y, Champlin R, Shpall E, Rezvani K, Ariza-Heredia EJ, Chemaly RF. Refractory and Resistant Cytomegalovirus after Hematopoietic Cell Transplant in the Letermovir Primary Prophylaxis Era. Clin Infect Dis. e-Pub 2021. PMID: 33830182.
164. Malek AE, Adachi JA, Mulanovich VE, Sassine J, Raad II, McConn K, Seiler GT, Dhal U, Khawaja F, Chemaly RF. Immune Reconstitution and Severity of COVID-19 among Hematopoietic Cell Transplant Recipients. Transpl Infect Dis:e13606. e-Pub 2021. PMID: 33755273.
165. Goldsmith SR, Abid MB, Auletta JJ, Bashey A, Beitinjaneh A, Castillo P, Chemaly RF, Chen M, Ciurea SO, Dandoy CE, Angel Diaz M, Fuchs EJ, Ganguly S, Kanakry CG, Kanakry JA, Kim S, Komanduri K, Krem M, Lazarus HM, Liu H, Ljungman P, Maziarz RT, Mulroney C, Nathan S, Nishihori T, Page KM, Perales MA, Taplitz RA, Romee R, Riches M. Post-Transplant Cyclophosphamide (PTCy) is Associated with Increased Cytomegalovirus Infection: A CIBMTR Analysis. Blood. e-Pub 2021. PMID: 33657221.
166. Ramanathan M, Kim S, He N, Chen M, Hematti P, Abid MB, Rotz SJ, Williams KM, Lazarus HM, Wirk B, Yin DE, Kanakry CG, Perales MA, Chemaly RF, Dandoy CE, Riches M, Ustun C. The incidence and impact of clostridioides difficile infection on transplant outcomes in acute leukemia and MDS after allogeneic hematopoietic cell transplant-a CIBMTR study. Bone Marrow Transplant. e-Pub 2022. PMID: 36543999.
167. Peacock WF, Chemaly RF, Torriani F, Shahid Z, Dadwal S. A New Normal for The Clinician's Third Hand: Stethoscope Hygiene and Infection Prevention. Am J Infect Control. e-Pub 2022. PMID: 36351475.
168. Khawaja F, Papanicolaou G, Dadwal S, Pergam SA, Wingard JR, Boghdadly ZE, Abidi MZ, Waghmare A, Shahid Z, Michaels L, Hill JA, Kamboj M, Boeckh M, Auletta JJ, Chemaly RF. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplant and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology. Transplant Cell Ther. e-Pub 2022. PMID: 36273782.

Invited Articles

1. Ong DSY, Chong GM, Chemaly RF, Cremer OL.. Comparative clinical manifestations and immune effects of cytomegalovirus infections following distinct types of immunosuppression. Clin Microbiol Infect, 2022. PMID: 35709902.
2. El Chaer F, Auletta JJ, Chemaly RF. How I treat and prevent COVID-19 in Patients with Hematologic Malignancies and Recipients of Cellular Therapies. Blood, 2022. PMID: 35776899.
3. Algwaiz G, Aljurf M, Koh M, Horowitz MM, Ljungman P, Weisdorf D, Saber W, Kodera Y, Szer J, Jawdat D, Wood WA, Brazauskas R, Lehmann L, Pasquini MC, Seber A, Lu PH, Atsuta Y, Riches M, Perales MA, Worel N, Okamoto S, Srivastava A, Chemaly RF, Cordonnier C, Dandoy CE, Wingard JR, Kharfan-Dabaja MA, Hamadani M, Majhail NS, Waghmare AA, Chao N, Kröger N, Shaw B, Mohty M, Niederwieser D, Greinix H, Hashmi SK, WBMT and the CIBMTR Health Services and International Studies Committee.. Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee. Biol Blood Marrow Transplant 26(12):2181-2189, 2020. e-Pub 2020. PMID: 32717432.
4. Coomes EA, Al-Shamsi HO, Meyers BM, Alhazzani W, Alhuraiji A, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. Evolution of Cancer Care in Response to the COVID-19 Pandemic. Oncologist 14:10.1634/theoncologist.2020-0451(9):e1426-e1427, 2020. e-Pub 2020. PMID: 32536024.
5. Waghmar A, Abidi MZ, Boeckh M, Chemaly RF, Dadwal S, El Boghdadly Z. Guidelines for COVID-19 in Hematopoetic Cell Transplantation and Cellular Therapy Recipients. Blood Marrow Transplant 2020 Jul 28:S1083-8791(20)30460-2, 2020.
6. ElGohary GM, Hashmi S, Styczynski J, Kharfan-Dabaja MA, Alblooshi RM, de la Cámara R, Mohmed S, Alshaibani A, Cesaro S, Abd El-Aziz N, Almaghrabi R, Gergis U, Majhail NS, El-Gohary Y, Chemaly RF, Aljurf M, El Fakih R. The risk and prognosis of COVID-19 infection in cancer patients: A systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2020 Jul 30:S1658-3876(20)30122-9, 2020.
7. Al-Shamsi HO, Alhazzani W, Alhuraiji A, Coomes EA, Chemaly RF, Almuhanna M, Wolff R, Nuhad NK, Chua MLK, Hotte SJ, Meyers BM, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. . A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist(25(6):e936-e945), 2020.
8. Adashek JJ, Hajjar J, Chemaly RF, Kurzock R.. Are Cancer Patients at Higher Risk of Death With COVID-19?. J Immunother Precis Oncol 3(2):49-51, 2020.
9. Adashek JJ, Hajjar J, Chemaly RF, Kurzock R.. Are Cancer Patients at Higher Risk of Death With COVID-19?. J Immunother Precis Oncol 3(2):49-51, 2020.
10. Alvarez-Cardona JJ, Whited LK, Chemaly RF. . Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections. Future Microbiol(15:389-400), 2020.
11. Shigle TL, Handy VW, Chemaly RF. Letermovir and its role in the prevention of cytomegalovirus infection in seropositive patients receiving an allogeneic hematopoietic cell transplant. Ther Adv Hematol 11:2040620720937150, 2020. e-Pub 2020. PMID: 32637057.
12. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P, Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Clin Infect Dis 68(8):1420-1426, 2019. PMID: 30137245.
13. Chemaly RF, Hill JA, Voigt S, Peggs KS. In vitro comparison of currently available and investigational antiviral agents against pathogenic human double-stranded DNA viruses: A systematic literature review. Antiviral Res 163:50-58, 2019. e-Pub 2019. PMID: 30677427.
14. Foolad F, Aitken SL, Chemaly RF. Letermovir for the prevention of cytomegalovirus infection in adult cytomegalovirus-seropositive hematopoietic stem cell transplant recipients. Expert Rev Clin Pharmacol 11(10):931-941, 2018. e-Pub 2018. PMID: 30004790.
15. Ariza-Heredia EJ, Chemaly RF. Update on infection control practices in cancer hospitals. CA Cancer J Clin 68(5):340-355, 2018. e-Pub 2018. PMID: 29985544.
16. Ariza-Heredia EJ, Chemaly RF. Practical review of immunizations in adult patients with cancer. Hum Vaccin Immunother 11(11):0, 2015. e-Pub 2015. PMID: 26110220.
17. Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 59 Suppl 5:S344-51, 2014. PMID: 25352629.
18. Ariza-Heredia EJ, Chemaly RF. Infection Control Practices in Patients With Hematological Malignancies and Multidrug-Resistant Organisms: Special Considerations and Challenges. Clinical Lymphoma, Myeloma & Leukemia 14(S3):104-10, 2014.
19. Chemaly RF, Simmons S, Dale C, Ghantoji SS, Rodriguez M, Gubb J, Stachowiak J, Stibich M. The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment. Ther Adv Infect Dis 2(79):79-90, 2014. PMID: 25469234.
20. Tverdek FP, Rolston KV, Chemaly RF. Antimicrobial Stewardship in Patients with Cancer. Pharmacotherapy 32(8):722-734, 2012. PMID: 23307520.
21. Shah DP, Ghantoji SS, Mulanovich VE, Ariza-Heredia EJ, Chemaly RF. Management of respiratory viral infections in hematopoietic cell transplant recipients. Am J Blood Res 2(4):203-18, 2012. e-Pub 2012. PMID: 23226621.
22. Shah JN, Chemaly RF. Management of RSV infections in adult recipients of hematopoietic stem cell transplantation. Blood 117(10):2755-63, 2011. e-Pub 2010. PMID: 21139081.
23. Vigil KJ, Adachi JA, Chemaly RF. Analytic Review: Viral Pneumonias in Immunocompromised Adult Hosts. Journal of Intensive Care Medicine 25(6):307-26, 2010.
24. Vigil KJ, Chemaly RF. Valacyclovir: approved and off-label uses for the treatment of herpes virus infections in immunocompetent and immunocompromised adults. Expert Opin Pharmacother 11(11):1901-13, 2010. e-Pub 2010. PMID: 20536295.
25. Georgescu G, Chemaly RF. Palivizumab: Where to from here?. Expert Opin Biol Ther 9(1):139-47, 2009. PMID: 19063700.
26. Ariza-Heredia EJ, Nesher L, Chemaly RF. Cytomegalovirus Diseases after Hematopoietic Stem Cell Transplantation: a Mini-Review. Cancer Lett. e-Pub 2013. PMID: 24041869.
27. El Chaer F, Shah DP, Chemaly RF. How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients. Blood. e-Pub 2016. PMID: 27760756.
28. Shah DP, Shah PK, Azzi JM, El Chaer F, Chemaly RF. Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review. Cancer Lett. e-Pub 2016. PMID: 27260872.
29. El Haddad L, Harb CP, Gebara MA, Stibich MA, Chemaly RF. A Systematic and Critical Review of Bacteriophage Therapy against Multi-Drug Resistant ESKAPE Organisms in Humans. Clin Infect Dis. e-Pub 2018. PMID: 30395179.
30. Batista MV, Haddad LE, Chemaly RF. Paramyxovirus infections in hematopoietic cell transplant recipients. Curr Opin Infect Dis. e-Pub 2018. PMID: 30320640.
31. Shahani L, Ariza-Heredia EJ, Chemaly RF. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther. e-Pub 2017. PMID: 28067078.
32. Khawaja F, Batista MV, El Haddad L, Chemaly RF. Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management. Curr Opin Infect Dis. e-Pub 2019. PMID: 31567572.
33. Pergam SA, Englund JA, Kamboj M, Gans HA, Young JH, Hill JA, Savani B, Chemaly RF, Dadwal SS, Storek J, Duchin J, Carpenter PA. Preventing Measles among Immunosuppressed Cancer and Hematopoietic Cell Transplant Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. e-Pub 2019. PMID: 31394271.
34. Khawaja F, Chemaly RF. Respiratory syncytial virus in hematopoietic cell transplant recipients and hematologic malignancy patients. Haematologica. e-Pub 2019. PMID: 31221784.
35. Ong DSY, Fragkou PC, Schweitzer VA, Chemaly RF, Moschopoulos CD, Skevaki C, European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). How to interpret and use COVID-19 serology and immunology tests. Clin Microbiol Infect. e-Pub 2021. PMID: 33975005.
36. Khawaja F, Spallone A, Kotton CN, Chemaly RF. Cytomegalovirus infection in transplant recipients: Newly approved additions to our armamentarium. Clin Microbiol Infect. e-Pub 2022. PMID: 35843567.

Editorials

1. Spallone A, Ariza-Heredia EJ, Chemaly RF.. Acute and Latent Viral Infections in Immunocompromised Patients: A Tale of Brave Battles and Menacing Foes. Clin Microbiology Infect, 2022. PMID: 35724870.
2. Leibovici L, Rodríguez-Baño J, Chemaly RF, Cutler S, Huttner A, Kalil AC, Leeflang M, Lina G, Paul M, Scudeller L, Tassios PT, Yusuf E.. Prediction Models in CMI. Clin Microbiol Infect, 2021. PMID: 34902543.
3. Chemaly RF. The ever-growing world of infections in immunocompromised patients: major headways with numerous shortcomings. Clin Microbiol Infect, 2021. PMID: 34256140.
4. Carpenter PA, Papanicolaou G, Chemaly RF, Boeckh M, Savani BN. American Society for Transplantation and Cellular Therapy Infectious Disease Guidelines: Preface to the Series. Transplant Cell Ther 27(2):103-104, 2021. PMID: 33830021.
5. Adashek JJ, Hajjar J, Chemaly RF, Kurzrock R. Are Cancer Patients at Higher Risk of Death With COVID-19?. J Immunother Precis Oncol 3(2):49-51, 2020. PMID: 34532715.
6. Chemaly RF, Clark TW.. Viral Therapeutics: where we are and where we are going. Curr Opin Infect Dis 31(6):512-513, 2018.
7. Torres HA, Chemaly RF. Viral infection or reactivation in patients during treatment with dasatinib: A call for screening. Leuk Lymphoma 48(12):2308-9, 2007.
8. Khawaja F, Chemaly RF. Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now?. Bone Marrow Transplant. PMID: 35220411.

Abstracts

1. Georgios Angelidakis, Roy F. Chemaly, Partow Kebriaei, Nadim J. Ajami, Pranoti V Sahasrabhojane, Micah M. Bhatti, Elizabeth Shpall, Chitra Hosing, Preetesh Jain, Kris Michael Mahadeo, Fareed Khawaja, Jennifer A. Wargo, Robert R. Jenq, Ella Ariza-Heredia. Evaluation of Antibody Titers and Antibody Response to Immunizations in Survivors of Immune Effector Cell Therapy. Poster Presentation at The European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), 2022.
2. Rita Wilson Dib, Amy Spallone, Fareed Khawaja, Jalen Bartek, Sherry Cantu, Tanya Dvorak, Adina Feldman, Hilary McMurry, Laila Nahavandi, Kim Nguyen, Crystal Odom, Amy Hankins, Linda Graviss, Roy F Chemaly. Characteristics of Hospital onset SARS CoV-2 infections before and after the emergence of the highly transmissible variant B.1.1.529 in a comprehensive cancer center. Poster presentation at ID Week 2022, 2022.
3. Rita Wilson Dib, Amy Spallone, MD, Fareed Khawaja, Jalen Bartek, Sherry Cantu, Tanya Dvorak, Adina Feldman, Hilary McMurry, Laila Nahavandi, Kim Nguyen, Crystal Odom, Amy Hankins, Linda Graviss, Roy F Chemaly. The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center. Poster presentation at ID Week 2022, 2022.
4. Marilyne Daher, Fareed Khawaja, Georgios Angelidakis, Gabriella Rondon, Amy Spallone, Jeremy Ramdial, Ella J Ariza-Heredia, Elizabeth Shpall, Roy F Chemaly. Predictive value of the immunodeficiency scoring index for COVID-19 related outcomes in hematopoietic transplant recipients. Poster presentation at ID Week 2022, 2022.
5. Anthony Febres-Aldana, Krithika Srinivasan, Oscar Morado-Aramburo, Fareed Khawaja, Amy Spallone, Roy F Chemaly, MD, MPH. Long-term hematopoietic cell transplant (HCT) outcomes in patients at high risk with cytomegalovirus (CMV) infection in the era of letermovir: a case-control study. Oral Presentation at ID Week 2022, 2022.
6. Oscar Morado-Aramburo, Amy Spallone, Fareed Khawaja, Anthony Febres-Aldana, Krithika Srinivasan, Gaby Rondon, Roy F Chemaly, MD, MPH. The Impact of Donor CMV Serostatus on Outcomes of CMV infections in the era of letermovir. Poster presentation at ID Week 2022, 2022.
7. Krithika Srinivasan, Anthony Febres-Aldana, Oscar Morado-Aramburo, Fareed Khawaja, Amy Spallone, Roy F Chemaly, MD, MPH. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir. Poster presentation at ID Week 2022, 2022.
8. Amy Spallone, Fareed Khawaja, Ella Ariza-Heredia, Genovefa A. Papanicolaou, Michael J. Boeckh, Sanjeet S. Dadwal, Maheen Z. Abidi, Jose F. Camargo, Zeinab El Boghdadly, Zainab Shahid, Roy F. Chemaly. Transplant providers’ perceptions of COVID-19 vaccination in the wake of a global pandemic. The European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), 2022.
9. Amy Spallone, Rita Wilson Dib, Fareed Khawaja, Roy F Chemaly, MD, MPH. The impact of the COVID-19 pandemic on hospital-acquired infections at a comprehensive cancer center. The International Immunocompromised Host Society (ICHS), 2022.
10. Amy Spallone, Rita Wilson Dib, Fareed Khawaja, Roy F Chemaly, MD, MPH. Hospital onset SARS CoV-2 infections before and after the emergence of the highly transmissible variant B.1.1.529 in a comprehensive cancer center. The International Immunocompromised Host Society (ICHS), 2022.
11. Roy F. Chemaly, Robin K. Avery, Sanjeet S. Dadwal, Nassim Kamar, Johan Maertens, Genovefa A. Papanicolaou, Oliver Witzke, Joan Gu, Jessica Auciello. Impact of Time From Transplant to Treatment of Patients With Refractory Cytomegalovirus Infection: Post Hoc Analysis of Phase 3 SOLSTICE Study. The International Immunocompromised Host Society (ICHS), 2022.
12. Joseph Sassine, MD, Fareed Khawaja, MD, Brandon R. Shank, PharmD, BCOP, Alexandra Lovell, PharmD, Jenessa Lee, PharmD, Adam DiPippo, PharmD, Caitlin Rausch, PharmD and Roy F. Chemaly, MD, MPH, FIDSA, FACP.. Letermovir Use in Patients with Relapsed or Refractory Hematological Malignancies. Poster Presentation at the American Society for Transplantation and Cellular Therapy, 2021, 2021.
13. Rafael F Duarte, Sophie Alain, Roy F Chemaly, Catherine Cordonnier, Johan Maertens, Jo-Anne Young, Jingyang Wu, Aimee Sundberg. Maribavir vs. investigator-assigned therapy (IAT) for the treatment of transplant recipients with refractory/resistant (R/R) cytomegalovirus infection: efficacy data from a randomized phase 3 open-label study. Presentation at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT): Physicians Award Winners/Presidential symposium, 2021, 2021.
14. Hachem Y, et al.. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19 Impact of Risk Factors and Treatment Modalities on Outcome. Oral presentation at ID Week 2021, 2021.
15. Georgios Angelidakis, Roy F. Chemaly, Partow Kebriaei, Nadim J Ajami, Micah M Bhatti, Elizabeth Shpall, Chitra Hosing, Preetesh Jain, Kris Michael Mahadeo, Fareed Khawaja, Jennifer Wargo, Robert Jenq,Ella Ariza Heredia,. Evaluation of Retained Immunity for Tetanus-Diphtheria and Pneumococcal Vaccines in Recipients of Cellular Therapies. Poster presentation at ID Week 2021, 2021.
16. Amy Spallone, Krithika Srinivasan, Joseph Sassine, Terri Lyn Shigle, Victoria Wehr Handy, Jeremy Ramdial, Fareed Khawaja, Ella Ariza-Heredia, Roy F Chemaly, MD.. The Impact of Clinically Significant CMV Infections on Other Viral Infections in the Era of Letermovir Primary Prophylaxis. Poster presentation at ID Week 2021, 2021.
17. Joseph Sassine, Fareed Khawaja, Brandon R Shank, Alexandra Lovell, Jenessa Lee, Adam DiPippo, Caitlin Rausch, Amy Spallone, Ella Ariza-Heredia, Roy F Chemaly.. Clinically Significant CMV Infections in Patients with Lymphoma or Multiple Myeloma. Poster presentation at ID Week 2021, 2021.
18. Fareed Khawaja, Carmen Sadaka, Samantha Trager, Kerri Fernandes, Ella J. Ariza-Heredia, Amy Spallone, Michelle Altrich, Roy F. Chemaly.. The use of a commercially available CMV T Cell Immunity Panel to Assess the Risk of CMV Infections in Hematopoietic Cell Transplant Recipients with Low Level CMV Viremia. Poster presentation at ID Week 2021, 2021.
19. Kimberly Workowski, Joerg Albrecht, Robin Avery, Pranatharthi Chandrasekar, Roy Chemaly, Nicolas Issa, Camille Kotton, Princy Kumar, Mayur Ramesh, Moti Ramgopal, Josuha Schiffer, Tanya Schreibman, Anna Wald, Michael Ison.. Pritelivir in Immunocompromised Patients with Mucocutaneous Acyclovir-Resistant Herpes Simplex Virus-Infections – First Case Series. Poster presentation at ID Week 2021, 2021.
20. Fareed Khawaja, Kathleen Mullane, Ella Ariza Heredia, Lynn El Haddad, Yuexin Tang , Amit D. Raval, Roy F. Chemaly. . Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis. Presentation at IDWeek, 2020.
21. Joseph Sassine, Fareed Khawaja, Victoria Handy, Terri Lynn Shigle, Farnaz Foolad, Ella Ariza Heredia and Roy F Chemaly. Refractory and Resistant CMV Infections in Hematopoietic Cell Transplant Recipients in the Letermovir Primary Prophylaxis Era. Presentation at IDWeek, 2020.
22. Fareed Khawaja, Mark Duna, Patrick Chaftari, Jean Tayar, Ella Ariza Heredia and Roy Chemaly. Outcomes of respiratory viral infections in cancer patients receiving checkpoint inhibitors. The European Congress for Clinical Microbiology and Infectious Diseases (ECCMID), 2020.
23. Siddhartha Ganguly, Randy Taplitz, Carolyn Mulroney, Richard T. Maziarz, Soyoung Kim, Min Chen, Roy F. Chemaly, Krishna V. Komanduri. Incidence and Impact of Cytomegalovirus Infection in Haploidentical and Matched-Related Donors Receiving Post-Transplant Cyclophosphamide (PTCy): A CIBMTR Analysis. Presentation at the American Society for Transplantation and Cellular Therapy, 2020.
24. Anurag K Singh, Ephraim J. Fuchs, Asad Bashey, Stefan O. Ciurea, Scott R Goldsmith, Siddhartha Ganguly, Randy Taplitz, Carolyn Mulroney, Richard T. Maziarz, Soyoung Kim, Min Chen, Roy F. Chemaly, Krishna V. Komanduri Miguel Perales, Rizwan Romee, and Marcie L Riches. Incidence and Impact of Non-CMV Herpes Viral Infection in Haploidentical and Matched Sibling Donors Receiving Post-Transplant Cyclophosphamide (PTCy): A CIBMTR Analysis. Presentation at the American Society for Transplantation and Cellular Therapy, 2020.
25. El Haddad L, Chaftari CP, Yusuf ST, Chemaly RF. The Nasal Microbiome as a Predictor of Infectious Complications after Hematopoietic Cell Transplant Patients. Biol Marrow Transplant 2, 2020.
26. Chemaly RF, Boeckh M, Weber K, Fleischhackl, Stevens M, Michiels B, Rivas D, Chien J, Witek J. FREEZIA Study Design: JNJ-53718678 in Hematopoietic Stem Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Upper Respiratory Tract. Poster Presentationat the American Society of Hematology, 2019.
27. De-la-Rosa D, Khawaja F, Batista M, Ariza EJ, Chemaly RF. . Respiratory Viral Infections in Patients with Lymphoma and Multiple Myeloma: Risk Factors Associated with Progression to Lower Respiratory Tract Infections. Poster Presentation at ID Week, Washington DC,, 2019.
28. El Haddad L, Harb CP, Stibich M, Chemaly RF. Bacteriophage Therapy Improves Survival of Galleria mellonella Larvae Injected with Vancomycin-Resistant Enterococcus faecium. Poster Presentation at ID Week, Washington DC, 2019.
29. Khawaja F, Duna M, Chaftari P, Chemaly RF. Outcomes Related to Respiratory Viral Infections in Cancer Patients on PD-1 Inhibitors. Poster Presentationat the ID Week, Washington DC, 2019.
30. El Haddad L, Gebara M, Harb CP, Stibich M, Chemaly RF. The Use of Bacteriophages to Inhibit Different Strains of Vancomycin-Resistant or Susceptible Enterococci. Poster Presentation at the ID Week, Washington DC, 2019.
31. Ye X, Iwuchukwu O, Avadhanula V, Chemaly R. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (P27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Hematopoietic Cell translplant (HCT) Adults, 2019.
32. Ye X, Iwuchukwu O, Avadhanula V, Chemaly R. Antibody Response to the Furin Cleavable Twenty-Seven Amino Acid Peptide (P27) of the Fusion Protein in Respiratory Syncytial Virus (RSV) Infected Hematopoietic Cell translplant (HCT) Adults. Presentation at RSVVW 2019 meeting, 2019.
33. Batista M, Chemaly RF. High Mortality of CMV Pneumonia in Hematopietic Cell Transplant Recipients. Poster presentation at ASBMT Tandem Meeting. Houston, Texas, 2019.
34. Batista M, Chemaly RF. Clinical Validation of the Definitions of Resistant and Refractory Cytomegalovirus (CMV) Infection and Disease in Hematopoietic Cell Transplant (HCT) Recipients. Poster presentation at ASBMT Tandem Meeting. Houston, Texas, 2019.
35. Chemaly RF. A post-hoc analysis of the randomized, double-blind, placebo-controlled multicenter phase 2 trial to examine the effects of DAS181 in hematopoeitic cell transplant (HCT) recipients with parainfluenza virus (PIV) lower respiratory tract infection (LRTI) on supplemental oxygen (SO. Oral presentation at the ASBMT, TCT meeting. Houston, Texas, 2019.
36. Chemaly RF. A post-hoc analysis of the randomized, double-blind, placebo-controlled multicenter phase 2 trial to examine the effects of DAS181 in hematopoeitic cell transplant (HCT) recipients with parainfluenza virus (PIV) lower respiratory tract infection (LRTI) on supplemental oxygen (SO). Oral presentation at the ASBMT, TCT meeting. Houston, Texas, 2019.
37. Artau A, Aitken S, Batista M, El Chaer F, Prayag A, El Haddad L, Mulanovich V, Ariza-Heredia E, Chemaly RF. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplan. Poster presentation at ID Week. San Francisco, CA, 2018.
38. El Haddad, Hanson, B, Arias, Otero G, Harb C, Ghantoji S, Stibich M, Chemaly RF. Transmission of Genetically Related, Multidrug Resistant, and Invasive Vancomycin-Resistant Enterococci (VRE) between Patients and Rooms on the Stem Cell Transplant (SCT) and Leukemia (LKM) Units. Poster Presentation at ID Week 2018 San Francisco, CA, 2018.
39. Kulkarni P, Kmeid J, Batista M, El Chaer F, Ariza-Heredia E, Graviss EA, Mulanovich V, Chemaly RF. Comparison of Interferon-gamma Release Assays (IGRAs) for Diagnosis of Latent or Active Tuberculosis in Cancer Patients. Poster presentation at ID Week. San Francisco, CA,, 2018.
40. Batista M, Khawaja F, Artau A, Aitken S, El Haddad L, Ghantoji S, Chemaly RF. High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients. Poster Presentation-ID Week 2018 San Francisco, CA, 2018.
41. Kontoyiannis D, Shah E, Graviss L, Raad I, Chemaly RF. Culture-documented invasive mold infections (cIMIs) at MD Anderson Cancer Center (MDACC) in Houston, TX pre and post hurricane Harvey. Poster Presentation-ID Week 2018 San Francisco, CA, 2018.
42. Magira E, Chemaly RF, Jiang Y, Kontoyiannis D. Invasive pulmonary aspergillosis (IPA) complicating respiratory viral infections in patients with hematological malignancies. Poster Presentation-ID Week 2018 San Francisco, CA, 2018.
43. Khawaja F, Shigle T, Ghantoji S, Batista M, Ariza-Heredia E, Chemaly RF. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients. Poster Presentation-ID Week 2018 San Francisco, CA, 2018.
44. Chemaly RF, Moss R, Marty Francisco, et.al. A randomized, double-blind, placebo-controlled multicenter phase 2 trial to examine the effects of DAS181 in immunocompromised (IC) patients with parainfluenza virus (PIV) lower respiratory tract infection (LRTI) on supplemental oxygen (SO). Oral presentation at ID Week, 2018.
45. Artau A, Aitken S, Batista M, El Chaer F, Prayag A, El Haddad L, Mulanovich V, Ariza-Heredia E, Chemaly RF. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplantation. Poster Presentation at ID Week 2018 San Francisco, CA, 2018.
46. Khawaja F, Shigle T, Ghantoji S, Batista M, Ariza-Heredia E, Chemaly RF. . The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients. Poster Presentation at ID Week 2018 San Francisco, CA, 2018.
47. Symeon M, Andes D, Chemaly RF, Giannella J, et. al. Meropenem-vaborbactam versus best available therapy for carbapenem-resistant Enterobacteriaceae infections in TANGO II: outcomes in all treated patients regardless of pathogen. Oral presentation at European Congress of Clinical Microbiology and Infectious Diseases. Madrid, Spain, 2018.
48. Boeckh M, Dadwal S, Bergeron A, Chemaly RF, et. al. A Phase 2B, Randomized, Double-Blind, Placebo-Controlled Trial 09:20-09-30 of Presatovir (GS-5806) For Treatment of Hematopoietic-Cell Transplantation Patients with An Respiratory Syncytial Virus Upper Respiratory Tract Infection. Oral presentation at the 44th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), Lisbon, Portugal, 2018.
49. Ghantoji S, Jiang Y, El Haddad L, Chemaly RF. Clinical Characteristics and Economic Burden of Respiratory Syncytial Virus (RSV) Infections in Hematopoietic Cell Transplant (HCT) Recipients. Poster presented at the Blood and Marrow Transplantation Tandem Meeting. Salt Lake City, Utah,, 2018.
50. Artau A, Aitken SL, El Chaer F, Prayag A, El Haddad L, Mulanovich VE, Shah DP, Ariza-Heredia EJ, Chemaly RF.. Outcomes of Resistant or Refractory CMV Infection in Recipients of Allogeneic Hematopoietic Cell Transplant. Poster presentation at ASBMT Tandem Meeting. Salt Lake City, UT, 2018.
51. Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji SS, Ariza-Heredia EJ, Chemaly RFSL, Shigle TL, Prayag A, Ghantoji SS, Ariza-Heredia EJ, Chemaly RF. Impact of Ribavirin Formulation and Host Risk Factors on 90-Day Mortality in Hematopoietic Cell Transplant (HCT) Patients with RSV Infection. Poster presentation at ASBMT Tandem Meeting. Salt Lake City, UT, 2018.
52. El Haddad L,Chemaly RF. The Successful Recovery of Bacteriophages with Activity against Vancomycin-Resistant Enterococci (VRE) from Stool Samples of Hematopoietic Cell Transplant (HCT) Recipients. Poster Presentation - ID Week 2017 San Diego, CA, 2017.
53. El Haddad L, Chemaly RF. The Successful Recovery of Bacteriophages with Activity against Vancomycin-Resistant Enterococci (VRE) from Stool Samples of Hematopoietic Cell Transplant (HCT) Recipients. Poster Presentation - ID Week 2017 San Diego, CA, 2017.
54. Ghantoji S, Chemaly RF. Clinical and Economic Burden of Respiratory Viral Infections in Hematopoietic Stem Cell Transplant Recipients: The MD Anderson Experience. Poster Presentation-ID Week 2017 San Diego, CA, 2017.
55. Foolad F, Chemaly RF. Use of Oral Ribavirin for the Treatment of RSV infections in HCT recipients. Poster Presentation-ID Week 2017 San Diego, CA, 2017.
56. El Haddad L, Chemaly RF. Single Nucleotide Polymorphisms (SNPs) Analyses Reveal Potential Vancomycin-Resistant Enterococci (VRE) Transmission Networks Between Rooms and Patients in a Hospital Setting. Poster Presentation-ID Week 2017 San Diego, CA, 2017.
57. Chemaly RF, et al.. A prospective Observational Study to Evaluate a CMV-specific ELISPOT Assay in Allogeneic Hematopoietic Cell Transplant Recipients: The REACT Study. Oral Presentation at the 20th European Symposium in Clinical Virology, Stresa, Italy,, 2017.
58. Chemaly, S. Dadwal, F. Marty, P., et. al. Safety and tolerability of letermovir prophylaxis of cytomegalovirus (CMV) infection in adult CMV-seropositive recipients of allogeneic haemato poietic cell transplantation (ALLO-HCT). Oral presentation at European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 2017.
59. E. Ariza Heredia, J. Hwang, G. Viola, R. Chemaly, et. al. Time to re-evaluate recommendations for prevention of human papillomavirus (HPV) infections after stem cell transplantation (HSCT). Poster presented at European Congress of Clinical Microbiology and Infectious Diseases. Vienna, Austria, 2017.
60. 48. Sairah Ahmed, Jessica Hwang, Roy Chemaly, et. al. Risk Factors for HPV positivity in Patients who received Allogeneic Stem Cell Transplant. Oral presentation at European Society for Blood and Marrow Transplantation conference. Marseille, France, 2017.
61. Shah DP, Ariza-Heredia E, El Chaer F, El Haddad L, El-Haddad D, Prayag A, Nesher L, Rezvani K, Shpall EJ, Chemaly RF. The ability of CMV-specific ELISPOT assay to predict outcome of low level CMV reactivation in hematopoietic cell transplant recipients. Poster Presentation at the ID week. New Orleans, Louisiana, 2017.
62. Farnaz Foolad, Amrita Prayag, Shashank Ghantoji, Ella Ariza-Heredia, Roy F. Chemaly. The Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients. Poster Presentation at the American Society for Bone Marrow Transplant Tandem Meeting, Orlando, FL, 2017.
63. El Chaer F, Prayag A, Shah D, Mulanovich V, Ariza-Heredia E, Chemaly RF. Drug-Resistant Cytomegalovirus Infections in Hematopoietic Cell Transplant Recipients: A Single Center Retrospective Study. Poster Presentation at the American Society for Bone Marrow Transplant Tandem Meeting, Orlando, FL, 2017.
64. EAriza-Heredia E, Shah DP, Winston DJ, Rowley S, Mullane K, Chandrasekar P,Hari P,Avery R, Peggs KS, Kumar D,Nath R, Ljungman P, Mossad S, Dadwal S, Cruikshank W, Chemaly RF. The Impact of Pre- and Week 4 Post-Transplant CMV-Specific Elispot Assay on CMV Reactivation and Survival in CMV-Seropositive Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients. Oral Presentation at the American Society for Bone Marrow Transplant Tandem Meeting, Orlando, FL, 2017.
65. Ariza-Heredia E, Shah DP, Winston DJ, Rowley S, Mullane K, Chandrasekar P, Avery R, Hari P, Peggs KS, Kumar D, Nath R, Ljungman P, Mossad S, Dadwal S,Cruikshank W, Chemaly RF.. A Prospective Observational Study to Evaluate a Cytomegalovirus (CMV)-Specific Enzyme-Linked Immunospot (Elispot) Assay in Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Recipients: The REACT Study. Oral Presentation at the American Society for Bone Marrow Transplant Tandem Meeting, Orlando, FL, 2017.
66. Marty F, Ljungman P, Chemaly RF, et al. A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Letermovir for Prevention of CMV Infection in Adult CMV-Seropositive Recipients of Allogeneic HCT. Oral Presentation at the American Society for Bone Marrow Transplant Tandem Meeting. Orlando, FL, 2017.
67. El Chaer F, Shah DP, Kmeid, J, Ariza-Heredia E, Hosing CM, Chemaly RF. Human metapneumovirus infections in 83 hematopoietic cell transplant recipients. Poster Presentation at The American Society of Bone Marrow Transplantation, Tandem Meeting, 2016.
68. Kmeid, J, Shah DP, El Chaer F, Ariza-Heredia E, Graviss E, Mulanovich V, Chemaly RF. The Utility of Interferon-Gamma Release Assays (IGRAs) for the Diagnosis of Mycobacterium Tuberculosis (Mtb) in Hematopoietic Cell Transplant (HCT) Recipients. Poster Presentation at The American Society of Bone Marrow Transplantation, Tandem Meeting, 2016.
69. Ghantoji S, Shah DP, El Haddad L, Kmeid J, Park AK, Chemaly RF. Economic and Clinical Burden of Cytomegalovirus (CMV) Infections in Hematopoietic Cell Transplant (HCT) Recipients: A Cost Comparison Study Across 9 Major Cancer Centers in the U. S. Poster Presentation at The American Society of Bone Marrow Transplantation, Tandem Meeting, 2016.
70. Shah DP, Ghantoji S, Azzi JM, Avadhanula V, Kmeid J, El Chaer F, Ariza E, Shah N, Mulanovich V, Hosing CM, Piedra P, Chemaly RF. An Open Label, Block-Randomized, Ribavirin Efficacy Trial for Management of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients: Clinical and Economic Implications. Oral Presentation at The American Society of Bone Marrow Transplantation, Tandem Meeting, 2016.
71. Ghantoji S, Shah DP, Lairson DR, El Haddad L, Kmeid J, Park AK, Chemaly RF. The Economic and Clinical Burden of Respiratory Viral Infections in Hematopoietic Cell Transplant (HCT) Recipients: A Cost Comparison Study Across 19 Major Cancer Centers in the U. S. Oral Presentation at The American Society of Bone Marrow Transplantation, Tandem Meeting, 2016.
72. Vakil E, Faiz S, Shah DP, Kmeid J, El Chaer F, Bashoura L, Ariza-Heredia E, Chemaly RF. Evaluation of bronchoscopy and radiographic imaging in respiratory syncytial virus infection in hematologic malignancy and hematopoietic stem cell transplant patients. Poster Presentation at the American Thoracic Society Conference, San Francisco, CA, 2016.
73. Taremi M, Shah DP, El Haddad D, El Chaer F, El Haddad L, Chemaly RF.. Clinical impact of rhinovirus infection early after hematopoietic stem cell transplantation. Poster Presentation at the 42nd Annual Meeting of the European Society for Blood and Marrow Transplantation, Valencia, Spain, 2016.
74. Shah DP, Ajami N, Ghantoji S, Shelburne S, El-Haddad D, Shah PK, Piedra P, Shpall EJ, Kontoyiannis D, Chemaly RF. Nasal microbiota changes are associated with progression to LRI following respiratory syncytial virus URI in hematopoietic cell transplant recipients. Poster Presentation at the ID week. New Orleans, Louisiana, 2016.
75. Ariza-Heredia E, Shah DP, El Chaer F, Mullane K, Rowley S, Chandrasekar P, Winston D, Parameswaram H, Gillis H, Nath R, Kumar D, Mossad S, Ljungman P, Chemaly RF. A prospective observational study to evaluate a cytomegalovirus(CMV)–specific T-SPOT® assay in hematopoietic stem cell transplant recipients: The REACT Study Interim Data Review. Poster Presentation at the ID week. New Orleans, Louisiana, 2016.
76. Taremi M, Shah DP, El-Haddad D, El Chaer F, El Haddad L, Prayag A, Rondon G, Hosing C, Ariza-Heredia E, Chemaly RF. Rhinovirus infections (RhVI) in 233 hematopoietic cell transplant (HCT) recipients: A single center experience. Poster Presentation at the ID week. New Orleans, Louisiana, 2016.
77. Shah DP, Ghantoji S, Azzi JM, Avadhanula V, El Chaer F, Ariza E, Mulanovich V, Piedra P, Chemaly RF. Cost-effectiveness of the Immunodeficiency Scoring Index and Oral Ribavirin in the management of RSV infections in hematopoietic cell transplant recipients. Oral Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
78. Shah DP, Nesher L, Ariza E, Azzi JM, Siddiqui H, Ghantoji S, Marsh L, El Chaer F, Makedonas G, Rezvani K, Shpall EJ, Chemaly RF. Dynamics of CMV-specific T cell recovery in allogeneic hematopoietic cell transplant recipients: Implications for clinical outcomes. Oral Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
79. Ghantoji S, Shah DP, Park AK, Lairson DR, Chemaly RF. Economic and clinical burden of respiratory viral infections in hematopoietic cell transplant (HCT) recipients: A cost comparison study across 9 major cancer centers in the U.S. Oral Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
80. Kmeid, J, Shah DP, El Chaer F, Ariza-Heredia E, Graviss E, Mulanovich V, Chemaly RF. The utility of interferon-gamma release assays (IGRAs) for the diagnosis of Mycobacterium Tuberculosis (Mtb) in cancer patients. The 2015 ID Week, 2015.
81. El Chaer F, Shah DP, Kmeid, J, Ariza-Heredia E, Hosing CM, Chemaly RF. Human metapneumovirus (hMPV) infections in 135 cancer patients. The 2015 ID Week, 2015.
82. S. L. Aitken, J. J. Tarrand, L. M. Deshpande, F. P. Tverdek, S. A. Shelburne, R. F. Chemaly, R. A. Prince, K. V. I. Rolston, R. N. Jones, M. Castanheira. Dissemination of NDM-1 Among Diverse Enterobacteriaceae in Houston is Not Related to Plasmid-Mediated Spread. Poster Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
83. S. L. Aitken, J. Zhou, S. S. Ghantoji, D. P. Kontoyiannis, R. N. Jones, V. H. Tam, R. F. Chemaly. Pharmacokinetics (PK) and Safety of Intravesicular Cidofovir. Poster Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
84. J. M. Baron, M. S. Mathisen, S. L. Aitken, S. S. Cantu, R. F. Chemaly, F. P. Tverdek. Evaluation of Previous Antibiotic Duration on the Risk for ESBL E. coli or Klebsiella spp. Bacteremia in Cancer Patients. Poster Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
85. S. L. Aitken, F. P. Tverdek, C. Wu, B. J. Atkinson, R. F. Chemaly. Impact of an Automated Antibiotic Time Out on Duration of Therapy in a Comprehensive Cancer Center. Oral Presentation at ICAAC, 55th Annual Meeting of the American Society for Microbiology, Interscience Conference on Antimicrobial Agents and Chemotherapy, 2015.
86. Kmeid, J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia E, Mulanovich V, Chemaly RF. Clinical outcomes following influenza including 2014/H3N2 infection in hematopoietic cell transplant (HCT) recipients. Poster Presentation, at the 2015 ID Week, 2015.
87. Shah D, Nesher L, Ghantoji SS, Michailidis L, Marsh L, Chemaly RF. Influenza Season. ID Week 2014, Philadelphia, PA, 2014.
88. Nesher L, Ariza-Heredia EJ, Shah DP, Azzi JM, Ghantoji SS, Marsh LY, Michailidis L, Rezvani K, Shpall EJ, Chemaly RF. Immune Monitoring with the T-SPOT. CMV assay of Allogeneic Hematopoietic Cell Transplant (HCT Recipients: A Proof of Concept in the Clinical Setting. Poster presentation at 54th ICAAC Conference in Washington, DC, 2014.
89. Nesher L, Ariza-Heredia EJ, Shah DP, Azzi JM, Ghantoji SS, Michailidis L, Rezvani K, Shpall EJ, Chemaly RF. The Impact of IL28b Polymorphism in Allogeneic Hematopoietic Cell Transplant (HCT) Recipients on Interferon (IFN y) Production and CMV Reactivation. Poster presentation at 54th ICAAC Conference in Washington, DC, 2014.
90. El Zakhem A, Shah D, Nobuyoshi M, Nesher L, Ariza-Heredia E, Mulanovich V, Kebriaei P, Hosing C, Rondon G, Chemaly R. The Clinical Significance of Human Herpes Virus 6 (HHV-6) Dnaemia in 68 Hematopoietic Cell Transplant Recipients (HSCT). Poster Presentation at BMT Tandem Meeting in Grapevine, Tx, 2014.
91. Vanichanan J, Shah DP, Nesher L, Ariza-Heredia E, Chemaly RF. Characteristics and Outcomes of Influenza a Infection in Hematologic Malignancy (HM) Patients and Hematopoietic Stem Cell Transplant. Poster Presentation at BMT Tandem Meetings in Grapevine, Tx, 2014.
92. Hamdi A, Kongtim P, Milton D, Alousi A, Anderlini P, Ciurea S, Oran B, Khouri I, Parmar S, Qazilbash M, Kebriaei P, Popat U, Rezvani K, Chemaly R, Shpall E, Champlin R, Bashir Q. The Effect of CMV Reactivation On Relapse and Survival In Patients With AML and MDS After Allogeneic Stem Cell Transplant (allo-HCT). Poster Presentation-55th ASH Annual Meeting and Exposition, 2013.
93. Chemaly RF. Validating an Immunodeficiency Scoring Index (ISI) to Predict Pneumonia and Mortality in Allogeneic Hematopoietic Stem Cell Transplant (allo-HCT) recipients with RSV, Influenza, and Parainfluenza Virus Infections, 2013.
94. Ghantoji SS, Stibich M, Stachowiak J, Simmons S, Tanner B, Perego C, Cantu S, Chemaly RF. Utilizing Pulsed-Xenon UV(PX-UV) as an alternative to sodium hypochlorite for the elimination of Clostridium difficile spores in the hospital environment. Poster Presentation at Infection Prevention Society of UK, 2013.
95. Ghantoji SS, Stibich M, Stachowiak J, Simmons S, Tanner B, Perego C, Cantu S, Chemaly RF. Reducing Transmission of Vancomycin Resistant Enterococci (VRE) in an immunocompromised patient population: Implementing a Novel Pulsed-Xenon Ultraviolet (PX-UV) Disinfection System in the Hospital Setting. Poster Presentation at Infection Prevention Society UK, 2013.
96. Ghantoji SS, Stibich M, Stachowiak J, Shah D, Simmons S, Tanner B, Perego C, Cantu S, Chemaly RF. Routine Incorporation of Pulsed Xenon UV (PX-UV) after Standard Cleaning of Rooms Previously Occupied by Patients with C. difficle (C.diff) or Vancomycin Resistant Enterococci (VRE) Infections or Colonizations. Poster Presentation at the 3rd Infections in Cancer Symposium, 2013.
97. Esmaily-Fard A, Tverdek F, Crowther D, Ghantoji SS, Adachi JA, Chemaly RF. The Use of Fidaxomicin for the Treatment of Clostridium Difficile Infection (CDI) in Patients with Cancer. Poster Presentation at ID Week 2013 in San Francisco, CA, 2013.
98. Vanichanan J, Nieto Y, Shah DP, Mulanovich VE, Ariza-Heredia E, Rondon G, Kontoyiannis D, Chemaly RF. Central Nervous System Complications after Hematopoietic Stem Cell Transplantation . Poster presentation at IDSA in San Francisco, CA, 2013.
99. Vanichanan J, Vilar-Compte D, Shah DP, Volkow P, Cornejo-Juarez P, Perez-Jimenez C, Saad M, Mulanovich VE, Ariza-Heredia E, Chemaly RF. A Multicenter Study of Pandemic H1N1 Influenza Infections in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant Recipients from 3 Countries. Poster presentation at IDSA in San Francisco, CA, 2013.
100. Ariza-Heredia E, Gulbis A, Stolar K, Kebriaie P, McConn K, Champlin R, Mulanovich V, Chemaly RF. Vaccination Guidelines after Stem Cell Transplantation: Practioners' Knowledge and Attitudes and the Gap between Guidelines and Clinical Practice. Oral Presentation at IDSA in San Francisco, CA, 2013.
101. Grimley, Chemaly R, Englund J, Yu L, Brundage T, Mommeja-Marin H, Kurtzberg J. The First Interventional Trial for Adenovirus (AdV): Brincidofovir (CMX001) for AdV in HCT. Oral Presentation at ICAAC in Denver, CO, 2013.
102. Nesher L, Shah DP, Rolston K, Mulanovich V, Ariza-Heredia E, Chemaly RF. Does fecal colonization with Pseudomonas aeruginosa (Ps. aeru) predict infection in recipients of allogeneic hematopoietic stem cell transplantation (allo-HSCT)?. Poster Presentation at IDSA in San Francisco, CA, 2013.
103. Mulanovich V, Shah D, Shah PK, Nguyen K, Perego C, Heredia E, Chemaly R. Herbaspirillum spp.: Clinical Characteristics of an Emerging Pathogen in Cancer Patients. Poster presentation at ID Week 2012 San Diego, CA, 2012.
104. Tverdek FP, Wu C, Mihu C, DeJesus Y,Heck W, Rolston KV, Chemaly RF. Antimicrobial Stewardship Initiative in Cancer Patients: The MD Anderson Cancer Center Experience. Poster presentation at The 15th Annual MAD-ID Meeting, May 10-12, 2012, Orlando, FL, 2012.
105. Tverdek FP, Wu C, Mihu C, DeJesus Y, Heck W, Rolston KV and Chemaly RF. Antimicrobial Stewardship Initiatives in Cancer Patients: The MD Anderson Cancer Center Experience. Poster Presentation at ID Week 2012 October 17-21, 2012, in San Diego, CA, 2012.
106. Chemaly RF. Antimicrobial Stewardship: Why and How in a Cancer Hospital. Poster presentation 24th Annual National Forum on Quality Improvement in Health Care, 2012.
107. RF Chemaly, G Ehninger, RE Champlin, MP Richard, H Zimmermann, S. Stoelben, P Lischka, D McCormick, H Rübsamen-Schaeff. Letermovir (AIC246) for the prevention of CMV infections meets primary endpoint in Phase 2b trial in human blood precursor cell transplant (HBPCT) recipients. Poster presentation at ICAAC 2012, 2012.
108. DP Shah, A Alousi, L Bashoura, Pankil, Mahajan S, Mulanovich V, Ariza E, RF Chemaly. Bronchiolitis Obliterans following Respiratory Viral Infections in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Oral presentation at ICAAC 2012, 2012.
109. Mahajan SN, Ghantoji SS, Shah DP, Mulanovich VE, Ariza E, Chemaly RF. Impact of RSV Infection in Patients with Lymphoma or Multiple Myeloma (MM): A Single Center Study. Oral presentation at ICAAC 2012, 2012.
110. Ghantoji SS, Stibich M, Stachowiak J, Tanner B, Perego C, Cantu S, Chemaly RF. Comparison of Pulsed Xenon UV (PX-UV) to Bleach for the Decontamination of C. difficile from Surfaces in the Patient Environment. Poster presentation at ICAAC 2012, 2012.
111. Chitasombat MN, Jiang Y, Torres HA, Tarrand J, Nguyen KT, Vu KD, Lerner S, Keating MJ, Chemaly RF. Cytomegalovirus Infection in Patients with Chronic Lymphocytic Leukemia. Poster presentation at the 49th Annual Meeting of the Infectious Diseases Society of America (IDSA), 2011.
112. Shah DP, Ghantoji SS, Shah JN, El Taoum KK, Hosing C, Rondon G, Popat U, Sorrentino M, Champlin R, Chemaly RF. Immunodeficiency Scoring System for Predicting RSV-associated Morbidity And Mortality In Allogeneic Hematopoietic Stem-cell Transplant Recipients. Poster presentation at the 51st ICAAC Conference, Chicago IL, 2011.
113. Ghantoji SS, Shah DP, Jiang Y, Shah JN, El Taoum KK, Hachem RY, Sorrentino MD, Popat U, Hosing C, Rondon G, Champlin RE, Chemaly RF. Characteristics and Outcomes of RSV Infections in 92 auto-HSCT Recipients. Oral presentation at the 51st Annual ICAAC, Chicago, IL, 2011.
114. Snyder E, Cardenas-Turanzas M, Perego C, Erfe R, Chemaly RF, KP Price, Nates JL. Respiratory Failure in Cancer Patients with Influenza A (H1N1) is Associated with Poor Prognosis. Poster presentation at the 31st International Symposium on Intensive Care and Emergency Medicine. Brussels, Belgium, 2011.
115. Dantes RB, Nguyen D, Modarai F, Pascoe N, Perego C, Chemaly RF, Lipuma JJ, O'Connell H, Noble-Wang J, Jensen B, Forster T, Guh A, MacCannell T. Herbaspirillum spp. Infections Among Oncology Patients-Texas, 2011. Oral Presentation at 61st Annual Epidemic Intelligence Service (EIS) Conference, 2011.
116. El Taoum K, Shah J, Sorrentino M, Popat U, Hosing C, Champlin R. Characteristics and Outcome of 284 Cases of Respiratory Syncytial Virus (RSV) Infection in Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) Patients: A Single Center Experience. Oral Presentation at the 7th International Respiratory Syncytial Virus Symposium. The Netherlands, 2010.
117. Mahale P, Davila M, Chemaly RF, Lewis RE, Hwang JP, Kontoyiannis DP, Torres HA. Acute Exacerbation of Chronic Hepatitis C in Cancer Patients. Poster Presentation at the 48th IDSA Annual Meeting. Vancouver, BC, Canada, 2010.
118. El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. The Characteristics and Outcome of Novel Influenza A (2009/H1N1) when Compared to Seasonal Influenza (SFlu) in Pediatric Cancer Patients. Oral Presentation at the 50th ICAAC Conference, Boston, MA, 2010.
119. Shah JN, El Taoum KK, Mosier M, Sorrentino MD, Murray R, Popat U, Hosing C, Rondon G, Tarrand JJ, Champlin RE, Chemaly RF. Characteristics and Outcome of 323 Cases of Respiratory Syncytial Virus (RSV) Infection in Hematopoietic Stem Cell Transplant (HSCT) Patients: A Single Center Experience. Boston, MA. Oral Presentation at the 50th ICAAC Conference, Boston, MA, 2010.
120. Shah JN, Mahajan SN, Hachem R, Adachi JA, Mulanovich V, Rolston KV, Raad II, Chemaly RF. Outcome of MRSA Bacteremia (BSI) in cancer patients treated with Vancomycin. Poster Presentation at the 48th IDSA Annual Meeting. Vancouver, BC, Canada, 2010.
121. Chitasombat, MN, Jiang Y, Torres H, Tarrand J, Chemaly RF. Cytomegalovirus Infection in Patients with Chronic Lymphocytic Leukemia. Poster Presentation at the IDSA 48th Annual Meeting. Vancouver, BC, Canada, 2010.
122. Chemaly RF, Vigil K, Adachi JA, Jiang Ying, Popat U, Mahani MG, Granwehr B, Malik Imrana, Gaeta S, Champlin R, Raad II. Novel Influenza A (2009/H1N1) Infection in Cancer Patients During the Outgoing Pandemic: Early Therapy Improves Outcome. Poster Presentation at the 48th Annual IDSA Meeting. Vancouver, BC, Canada, 2010.
123. Vigil K, Adachi JA, Jiang Y, Popat U, Mahani MG, Granwehr B, Gaeta S, Malik I, Champlin R, Raad II, Chemaly RF. Novel Influenza A (2009/H1N1) Infection in Patients with Hematologic Malignancies during the 2009 Pandemic Outbreak: Early Treatment Improves Survival. Poster Presentation at the 52nd ASH Annual Meeting. Orlando, FL, 2010.
124. Shah JN, Vigil KJ, Rathod DB, Mihu CN, Granwehr BP, Raad II, Chemaly RF. Respiratory Syncytial Virus (RSV) infection in children with cancer-to treat or not to treat?. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009, 2009.
125. Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Raad II, Chemaly RF. Influenza Virus Infections in Pediatric Cancer Patients-Emphasis on Preemptive Therapy. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009, 2009.
126. JA Adachi, CL Perego, KJ Vigil, VE Mulanovich, E Pravinkumar, C St John, II Raad, RF Chemaly, KV Rolston. Antibiotic Stewardship Initiative in the Intensive Care Unit (ICU): Evidence from a Quality Improvement Project Supporting the Development of a Multidisciplinary Antimicrobial Stewardship Team (MAST). Poster Presentation at the International Forum on Quality and Safety in Healthcare, Berlin, 2009.
127. Chemaly RF, Sikka MK, Rathod DB, Hayden MK, Hutchins M, Horn T, Tarrand J, Adachi J, Nguyen K, Raad I, Trenholme G. Clinical outcome of patients with Serratia marcescens Bacteremia (SMB) due to Contaminated Pre-Filled Heparin and Saline Flushes in 3 states. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009, 2009.
128. Shah JN, Hachem R, Rathod DB, Adachi AA, Mulanovich, VE, Raad II, Chemaly RF. Outcome of MRSA Bacteremia (BSI) in Cancer Patients Treated with Vancomycin. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009.
129. Shah JN, Vigil KJ, Hachem RY, Mihu CN, Mulanovich VE, Chemaly RF. Outcome of Parainfluenza Infection in Pediatric Cancer Patients-Underscoring the Need for PIV-Specific Antiviral Therapy. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009.
130. Rathod DB, Torres H, Munsell M, Bodey G, Davis M, Saifan C, Raad I, Champlin R, Chemaly RF. Continuous Versus Intermittent Dose Schedule of Aerosolized Ribavirin for Treatment of RSV Upper Respiratory Tract Infection (URI) in Pts with Hematological Malignancies: An Adaptive Randomized Trial. Oral Presentation at 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2009.
131. Rathod DB, Adachi JA, Vigil KJ, Shah JN, DuPont H, Hachem R, Raad II, Chemaly RF. Clostridium difficile Infection (CDI) in Cancer Patients: A Case-Control Study. Poster Presentation at 49th Interscience Conference on Antimicrobial Agents and Chemotherapy, 2009.
132. Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Raad II, Chemaly RF. Influenza Virus Infections in Cancer Patients-Emphasis on Preemptive Therapy. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009.
133. Shah JN, Vigil KJ, Rathod DB, Mihu CN, Granwehr BP, Raad II, Chemaly RF. Respiratory Syncytial Virus Infection in Children with Cancer - To Treat or Not to Treat?. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009.
134. Campo M, Hachem R, Jiang Y, Chemaly R, Carrilo-Marquez M, Hulton K, Raad I. Does Panton Valentine Leukocidin (PVL) Exotoxin Influence the Outcome of Cancer Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infection?. 47th Annual Meeting of the Infectious Diseases Society of America, Philadelphia, PA, 2009.
135. Chaftari A, Hachem R, Mulanovich V, Chemaly RF, Adachi JA, Kassar R, Ramos E, Jiang Y, Raad II. Efficacy and Safety of Daptomycin in the Treatment of Gram Positive Catheter-Related Bloodstream Infections (CRBSI) in Cancer Patients. Poster presentation at 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
136. Campo M, Hachem R, Jiang Y, Chemaly RF, Carrilo-Marquez M, Hulten K, Raad II. The Impact of Panton Valentine Leukocidin (PVL) Exotoxin on the Outcome of Cancer Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Infection. Poster presentation at 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
137. Chemaly RF, Hanmod S, Mulanovich V, Adachi J, Rolston K, Raad II, Hachem R. Tigecycline Usage in Cancer Patients with Serious Infections: A Report on 110 Cases from a Single Institution. Poster Presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
138. Chemaly RF, Tarrand J, Adachi J, Nguyen K, Graviss L, Mulanovich V, Granwehr B, Rolston K, Raad II. Investigation of an Outbreak of Serratia marcescens Bacteremia in Cancer Patients (pts) leading to a National Recall of a Second Unsuspected Contaminated Source: Time for Antimicrobial Lock Therapy (ALT)?. Oral Presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
139. Ramos ER, Hachem R, Mulanovich V, Adachi J, Kontoyiannis D, Rolston K, Safdar A, Chemaly RF. Characteristics and Outcome of Methicillin Resistant Staphylococcus aureus Pneumonia (MRSA-p) in Cancer Patients (pts) After Initial Therapy with Vancomycin. Poster presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
140. Rathod D, Vigil K, Adachi J, Burton L, Perego C, Jiang J, Dupont H, Raad I, Chemaly RF. Characteristics and Outcome of Clostridium difficile Infection (CDI) in Cancer Patients (pts). Poster presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
141. Hanmod S, Rathod D, Doshi A, Burton L, Davis MS, Chemaly RF. Characteristics and Outcome of Parainfluenza Virus (PIV) Infection in Patients (pts) with Leukemia and Hematopoietic Stem Cell Transplantation (HSCT) Recipients. Poster Presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
142. Ramos ER, Jiang Y, Hachem R, Reitzel R, Chaftari AM, Chemaly RF, Tarrand J, Raad II. The Risk of Emerging Resistance Associated with Prolonged Use of Antibiotic Coated Catheters: A Seven year Experience and >0.5 Million Catheter Days. Poster Presentation at The 48th Annual ICAAC/Infectious Diseases Society of America 46th Annual Meeting, Washington, DC, 2008.
143. Roy F. Chemaly, Linda Graviss, Jeffrey Tarrand, Xiang-Yang Han, P. Rocco LaSala, Javier Adachi, Rodolfo Morice, Issam Raad. Pseudo-outbreak of Mycobacterium mucogenicum Infection Associated with Contaminated Water Supply. Poster presentation at the SHEA's 18th Annual Scientific Meeting, Orlando, FL, 2008.
144. Boeckh M, Nichols G, Chemaly R, et al. Prevention of late CMV disease after HCT: A randomized double-blind multicenter trial of valganciclovir (VGCV) prophylaxis versus PCR-guided GCV/VGCV preemptive therapy. Poster presentation at the American Society for Blood and Marrow Transplant (ASBMT) 2008 Annual Meeting, 2008.
145. Roy F. Chemaly, Parikshit Sharma, Santosh Hanmod, Gloria Mattiuzzi, Maria Cabanillas, Hagop Kantarjian, Amar Safdar, Issam I. Raad. Cytomegalovirus infection in Patients with Acute Leukemia. Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, California, 2007.
146. Santosh Hanmod, Andre Baradhi, Dimitrios Kontoyiannis, Javier Adachi, Victor Mulanovich, Ray Y. Hachem, Amar Safdar, Issam Raad, Roy F. Chemaly. Cytomegalovirus infection in Patients with Solid Tumors. Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, California, 2007.
147. R. Hachem, RF. Chemaly, Y. Jiang, R. Reitzel, I. Raad. Anti-adherence Activity and Antimicrobial Durability of Anti-infective-Coated Catheters Against Multidrug-Resistant (MDR) Bacteria. Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, California, 2007.
148. R. Hachem, D.P. Kontoyiannis, RF. Chemaly, Y. Jiang, R. Reitzel, H. Kantarjian, I. Raad. Galactomannan Enzyme Immunoassay (GM-EIA): Low Sensitivity for Aspergillus fumigatus Infection in Cancer Patients (pts). Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, California, 2007.
149. Roy F. Chemaly, Parikshit S. Sharma, Souad Youssef, Donna Gerber, Ray Hachem, Issam I. Raad. Catheters Coated with Minocycline and Rifampin for the Prevention of Catheter Related Bacteremia (CRB) in Cancer Patients receiving High Dose Interleukin 2 (IL-2). Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, California, 2007.
150. I. Raad, R. Hachem, R. Teitzel, T. Dvorak, Y. Jiang, X. Fang, E. Ramos, R.F. Chemaly. Gardine Antiseptic Gloves Protect Health Care Workers (HCW) from Resistant Pathogens. Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting. San Diego, California, 2007.
151. Elizabeth Ramos, Ray Hachem, Victor Mulanovich, Javier Adachi, Dimitrios Kontoyiannis, Kenneth Rolston, Amar Safdar, Issam Raad, Roy F. Chemaly. MRSA Pneumonia in Cancer Patients: High Failure rate with Vancomycin. Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting, San Diego, California, 2007.
152. G A. Lamaris, B Esmaeli, G Chamilos, RE Lewis, R Chemaly, A Safdar, II Raad, DP Kontoyiannis. Fungal endophthalmitis (FE) in a tertiary cancer center: a review of 21 cases. Poster presentation at the Infectious Diseases Society of America (IDSA) 45th Annual Meeting, San Diego, California, 2007.
153. Rodriguez GH, Rolston KV, Chemaly RF, Raad II, Safdar A. Polymicrobial Bloodstream Infection in Cancer Patients. Poster presentation at the 45th Annual Meeting of Infectious Diseases Society of America (IDSA), San Diego, California, 2007.
154. Adachi JA, Perego C, Hogan H, Vigil K, Youssef S, Pravinkumar E, St. John C, Mulanovich V, Raad I, Chemaly R, Rolston K. Antibiotic stewardship initiative in the intensive care unit (ICU): Evidence from a quality improvement project supporting the development of a multidisciplinary antimicrobial stewardship team (MAST). Poster presentation at 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 2007.
155. Adachi JA, Vigil KJ,Aboufaycal H, Dvorak T, Hachem R, Tarrand JJ, Perego CA, Williams PA, Chemaly RF, Rolston KV, Raad II. Molecular Epidemiology of a Clonal Outbreak of Epidemic Multidrug-Resistant (MDR) Escherichia coli Causing Bloodstream Infection in Cancer Patients. Poster presentation at 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA, 2007.
156. RF. Chemaly, R. Hachem, S. Hanmod, J. Adachi, H. Hogan, V. Mulanovich, D. Kontoyiannis, A. Safdar, I. Raad, K. Rolston. Tigecycline usage in cancer patients with refractory pneumonia: a report on 38 cases. A single-institution study. Poster presentation at the combined 17th European Congress of Clinical Microbiology and Infectious Diseases and the 25th International Congress of Chemotherapy Munich, Germany, 2007.
157. Marty F, Chemaly RF, Liakopoulou E, Dent JC, Powell K. A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of RSV604 in Adults with Respiratory Syncytial Virus (RSV) Infection Following Stem Cell Transplantation. Presented at the International Symposium on Respiratory Infections, Hong Kong, 2007.
158. Winston D, van Burik JA, Pullarkat V, Papanicolaou Z, Vij R, Vance E, Alangaden G, Chemaly R, Petersen FB, Chao N, Klein J, Sprague K, Dougherty C, Villano S, Boeckh M. Prophylaxis against Cytomegalovirus Infections with Oral Maribavir in Allogeneic Stem Cell Transplant Recipients: Results of a Phase 2 Study. Oral presentation at the American Society of Hematology Orlando, FL, 2006.
159. Torres HA, Aguilera E, Rohatgi N, Raad II, Sepulveda C, Safdar A, Kontoyiannis DP, Chemaly RF*. Cytomegalovirus pneumonia (CMVp) in patients with hematologic malignancies (HM): An autopsy-based case-control study. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
160. Ghanem G, Gravis L, Chemaly RF, Hanna H, Dvorak T, Hulten K, Hachem R, Raad II. The role of molecular methods in the prevention of nosocomial methicillin resistant Staphylococcus aureus (MRSA) clusters in cancer patients. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
161. Youssef S, Hachem R, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Rolston K, Safdar A, Kontoyiannis D, Raad II. Vitamin B6 was not effective for the prevention of hematologic toxicities of linezolid (LNZ) in Cancer Patients (Pts). 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
162. Jain A, Champlin RE, Hachem R, El-Osta H, Kontoyiannis DP, Raad II, Chemaly RF*. The outcome of Parainfluenza virus (PIV) infection in recipients of hematopoietic stem cell transplantation (HSCT): Hype or concern?. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
163. Torres HA, Rodriquez G, Aguilera E, Rohatgi N, Raad II, Safdar A, Chemaly RF. Cytomegalovirus Adrenalitis (CMV-A): A challenging diagnosis in patients with hematologic malignancies (HM). 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
164. Torres HA, El-Osta H, Hachem R, Mattiuzzi G, Cabanillas M, Jain A, Raad II, Chemaly RF. Parainfluenza virus (Piv) infection in patients with leukemia commonly involves the lower respiratory tract. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
165. Chamilos G, Luna M, Lewis RE, Chemaly RF, Raad II, Kontoyiannis DP. Liver histopathology in patients (pts) with hematologic malignancy (HM) and invasive fungal infections (IFIs) treated with liposomal amphotericin B (L-AMB) vs. amphotericin B lipid complex (ABLC): An autopsy study. 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
166. Ghanem G, Hachem R, Jiang Y, Safdar A, Chemaly RF, Raad II. Comparative analysis of vancomycin resistant enterococcus (VRE) faecalis vs. VRE faecium in cancer patients (pts). 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
167. Shukrallah B, Ghannam D, Hackett B, Keutgen X, Jiang Y, Hachem R, Chemaly RF, Kontoyiannis DP, Hanna H, Raad II. The utility of >100 CFU from the central venous catheter (CVC) in establishing the diagnosis of catheter-related bloodstream infection (CRBSI). 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
168. Chemaly RF, Hachem R, Hanmod S, Adachi J, Hogan H, Kontoyiannis DP, Safdar A, Raad II, Rolston KVI. Clinical experience with tigecycline in cancer patients: A report on 28 cases. The Infectious Diseases Society of America (IDSA), Toronto, Ontario, 2006.
169. Ghannam DE, Rodriquez GH, Adachi J, Chemaly RF, Rolston KV, Raad II, Safdar A. Efficacy of inhaled (Ih)- Aminoglycosides (AG) and Colistin (CL) in cancer patients with ventilator-associated pneumonia (VAP) during 2000-2005. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), #A2701, San Francisco, CA, 2006.
170. Keutgen X, Ghannam D, Hackett B, Shukrallah B, Jiang Y, Chemaly RF, Hanna H, Hachem R, Raad II. Differential Quantitative Blood Cultures (QBC) for the Diagnosis of Catheter-Related Bloodstream Infection: What is the Cutoff Ratio?. 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), D-472, San Francisco, CA, 2006. e-Pub 2006.
171. Chemaly RF, Graviss L, Perego C, Hachem RY, Adachi J, Hogan H, Arbuckle R, Rolston K, Raad II. The temporary impact of an educational campaign on the decrease of carbapenems usage which correlated with decrease in the rate of nosocomial multidrug resistant (MDR) pseudomonas aeuroginosa (psa) infection. Annual Meeting at the Society for Healthcare Epidemiology of America (SHEA). Chicago, IL, 2006.
172. Adachi J, Gravis LS, Perego CH, Gonzalez VR, Hackett B, Hachem R, Hanna HA, Dvorak TL, Chemaly RF, Raad II. Controlling multidrug resistant pseudomonas aeruginosa in critically ill cancer patients: The role of interventional molecular epidemiology. Presentation at the 16th Annual Meeting at the Society for Healthcare Epidemiology of America (SHEA), #206 (32), 2006.
173. Aboufaycal, H, Adachi J, Hachem R, Weiss LT, Kontoyiannis D, Safdar A, Chemaly RF, Rolston K, Raad II. Risk factors and outcome of infection with multidrug-resistant (MDR) Escherichia coli in patients with cancer. 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #716, San Francisco, CA, 2005.
174. Aisenberg GM, Torres H, Tarrand J, Safdar A, Chemaly RF. Herpes simplex virus (HSV) in lower respiratory tract secretions (LRTS) in patients with solid tumors: Shedding or infection?. 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #711, San Francisco, CA, 2005.
175. Aisenberg, G, Sims C, Jacobson K, Chemaly RF, Rolston K, Raad II, Safdar A. Mycobacterium tuberculosis (MTB) infection: Clinical spectrum of active disease in patients at a comprehensive cancer center (2001-2005). 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #731, San Francisco, CA, 2005.
176. Hachem, RY, Chemaly RF, Ahmer C, Boktour MR, Rjaili GA, Weiss LT, Bodey GP, Raad II. Does colistin have a role in the treatment of infections caused by multidrug-resistant pseudomonas aeruginosa (MDR-PSA) in cancer patients?. 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #457, San Francisco, CA, 2005.
177. Hachem, R, Boktour M, Daugherty T, Pham-Williams T, Warneke C, Chemaly R, Raad I. The utility of galactomannan enzyme immunoassay (GM-EIA) and (1-3) B-D-glucan (BG) in the diagnosis of invasive fungal infections in cancer patients. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, 2005.
178. Kumashi, P, Safdar A, Chemaly RF, Chamilos G, Raad II, Kontoyiannis D. Fungal osteoarticular infections (FOAI) in cancer patients (PTS): A 10-year retrospective study. 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #742, San Francisco, CA, , 2005.
179. Torres, HA, Aguilera EA, Mattiuzzi G, Cabanillas M, Rohatgi N, Sepulveda C, Kantarjian H, Raad II, Chemaly RF. Respiratory syncytial virus infection in patients with leukemia: To treat or not to treat? . 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, 2005.
180. Ghanem, GA, Boktour M, Warneke W, Bahna BN, Kassis K, Chemaly RF, Hachem R, Raad II. Catheter-related staphylococcus aureus bacteremia (CRSAB) in cancer patients: high complication rate associated with type of malignancy. 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #726, San Francisco, CA, 2005.
181. Bahna BN, Hanna HA, Chemaly RF, Hachem RY, Raad I. Sources and outcomes of bloodstream infections (BSI) in cancer patients (pts): the role of quantitative blood cultures (QBC) and the central venous catheter (CVC). 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2005.
182. Bahna, BN, Hanna HA, Dvorak T, Chaiban G, Chemaly RF, Hachem RY, Raad II. Gendine coated orthopedic metal devices (OMDs) for the prevention of bacterial infection. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2005.
183. Chemaly RF. Human herpesviruses-6 (HHV- 6) viremia is associated with donor granulocyte transfusions (GTX) in heavily immunosuppressed patients (PTS) with leukemia. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), #V-592, Washington, DC, 2005.
184. Hachem RY, Hanna HA, Dvorak T, Chemaly RF, Raad II. Activity of daptomycin and tigacycline against clinical isolates causing catheter-related methicillin-resistant Staphylococcus aureus (cR-MRSA) embedded in biofilm. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2005.
185. Hogan, H, Tarrand J, Adachi J, Hachem R, Graviss L, Perego C, Raad I, Chemaly RF. Increase in enterococcal resistance to linezolid correlates with increase in linezolid usage: Collateral damage?. 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), New Orleans, LA, 2005.
186. Aguilera E, Torres HA, Mattiuzzi G, Cabanillas M, Kantarjian H, Gonzalez V, Raad II, Chemaly RF. Influenza infection in adult patients (PTS) with leukemia: The impact of neuraminidase inhibitors (NIS). 43rd Annual Meeting of The Infectious Diseases Society of America (IDSA), #723, San Francisco, CA,, 2005.
187. Aguilera E, Torres HA, Gonzalez VR, Raad II, Hachem RY, Frenzel EC, Thomas GA, Chemaly RF. The impact of influenza epidemic with a predominant mismatched circulating strain with the vaccine strain on patients with hematologic malignancies. Annual Meeting at the Society for Healthcare Epidemiology of America (SHEA), #20. Los Angeles, California, 2005.
188. Chamilos G, Bodey GP, Luna M, Lewis RE, Rolston KV, Chemaly RF, Safdar A, Raad I, Kontoyiannis DP. Trends in incidence of invasive fungal infections at a tertiary cancer center over a 14-year period: an autopsy study. Oral presentation at the 15th European Congress of Clinical Microbiology and Infectious Diseases, Copenhagen, Denmark,, 2005.
189. Chemaly RF, Gonzalez VR, Hachem RY, Perego CA, Donato ML, Champlin RE, Neumann JL, Johnson PA, Raad II. Detection and control of a nosocomial respiratory syncytial virus (RSV) outbreak in an adult bone marrow transplant unit: The role of palivizumab. Annual Meeting at the Society for Healthcare Epidemiology of America (SHEA), #78. Los Angeles, California,, 2005.
190. Lee LD, Berkheiser ML, Hackett B, Hachem RY, Chemaly RF, Raad II. The risk of bioaerosol contamination with Aspergillus species before and after terminal cleaning in hepa-filtered rooms housing patients with hematologic malignancy (HM). Annual Meeting at the Society for Healthcare Epidemiology of America (SHEA), #36. Los Angeles, California, 2005.
191. Hachem RY, Lee LD, Berkheiser ML, Hackett B, Chemaly RF, Perego C, Kontoyiannis DP, Raad II. Nosocomial invasive aspergillosis (NIA) in patients with hematologic malignancy: is it waterborne or airborne?. Annual Meeting at the Society for Healthcare Epidemiology of America (SHEA), #22. Los Angeles, California, 2005.
192. Chemaly RF, Perego C, Dvorak T, Toguchi A, Hulten K, Raad II. Outbreak of a Community acquired methicillin resistant Staphylococcus aureus (CA-MRSA) skin infection among healthcare workers (HCWs). . Presentation at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2004.
193. Hachem R, Boktour M, HannaH, Tarrand J, Kontoyiannis DP, Chemaly RF, Willams TP, Daugherty T, Raad I. Serum Galactomannan (GM): Which Assay (or LATEX) is Useful in Diagnosing Invasive Aspergillosis (IA)?. Annual Meeting of the Infectious Diseases Society of America (IDSA), #617, Boston, MA, 2004.
194. Kamana M, Chemaly RF, Coyle E, Hogan H, Raad, II. Foscarnet as First-Line Agent for Cytomegalovirus Infection or Prophylaxis in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT). Presentation at Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, MA, 2004.
195. Raad I, Graviss L, Chemaly RF, Hachem R, Hanna H. The Perils of Molecular Typing: Does a Clonal Cluster of Nosocomial MRSA always imply Nosocomial Transmission?. Presentation at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC, 2004.
196. Torres H, Younes A, Aguilera AA, Kontoyiannis DP, Luna MA, Tarrand JJ, Nogueras G, Raad I, Chemaly RF. Cytomegalovirus Infection in Patients (Pts) with Lymphoma. Presentation at Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, MA, 2004.
197. Torres HA, Chemaly RF, Storey R, Aguilera E, Luna M, Rolston KVI, Raad, Kontoyiannis DP. Pneumocystis Jiroveci Pneumonia in a Cancer Center: Influence of HIV Status to Presentation and Outcome. Presentation at Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, MA, 2004.
198. Torres HA, Luna MA, Kontoyiannis D, Tarrand JJ, Noguera GM, Chemaly RF. Gastrointestinal Cytomegalovirus Disease in Patients with Cancer. Oral presentation at the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAgAC), Washington, DC, 2004.
199. Raad II, Hachem RY, Boktour MR, Chemaly RF, Daugherty TC, Hanna HA. Real-time PCR and Galactomanan for the diagnosis of invasive aspergillosis in patients with hematological malignancies. Proceedings of the 42nd annual meeting of the infectious diseases society of America. Boston, MA, 2004.
200. Chemaly RF, Bahna B, Hachem R, Abu-Rijaily G, Waked A, Graviss L, King K, Weber R, Bekele N, Raad I. Risk Factors for Methicillin Resistant Staphylococcus Aureus (MRSA) Surgical Site Infection (SSI) in Patients ({Pts) with Cancer. Presentation at Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, MA, 2004.
201. Ohmagari N, Kontoyiannis DP, Chemaly RF, Hachem R, Raad II. Invasive Aspergillosis (IA) among Cancer Patients (pts) with Solid Tumor: A 10-year Experience at a Tertiary Cancer Hospital. Annual Meeting of the Infectious Diseases Society of America (IDSA), Boston, MA, 2004.
202. Chemaly RF, Procop GW, Kohn D, Yen-Lieberman B, et al. The Role of HHV-6 Detection in Bronchoalveolar Lavage and CMV Pneumonitis in Lung Transplant Recipients. Presentation at the 19th Clinical Virology Symposium, Clearwater, Florida, 2003.
203. Girgawy E, Hanna H, Graviss L, Chaiban G, Chemaly RF, et al. Chest Tube (CT) Related Multidrug-resistant Staphylococcus aureus (MRSA) Empyema: Could the CT Be Coated with Antiseptics? . Presentation at the 41st Annual Meeting of the Infectious Diseases Society of America (IDSA) San Diego, California, 2003.
204. Hogan H, Chemaly RF, Elizabeth Coyle, Mallika Kamana, et al. Early Combination Antiviral Therapy for Cytomegalovirus (CMV) Infection in Patients with Hematological Malignancies. Presentation at the 41st Annual Meeting of the Infectious Diseases Society of America (IDSA) San Diego, California, 2003.

Book Chapters

1. Alexander Franklin, Amy Spallone, Roy. F. Chemaly. CMV Diseases in Hematopoietic Cell Transplant Recipients. In: Pulmonary and Critical Care Considerations of Hematopoietic Stem Cell Transplantation (Editor: Ayman O. Soubani). Springer Nature Switzerland AG, 2022.
2. Ariza-Heredia E, El Chaer F, Chemaly RF. Antiviral Treatment and Prophylaxis in Immunocompromised Hosts. In: Management of Infections in the Immunocompromised Host. First Edition. Springer International Publishing AG, 2018.
3. Aitken S, Saunders R, Chemaly RF, Ehninger G. Letermovir. In: Kucers’ The use of Antibiotics. Seventh Edition. CRC Press, Taylor & Francis Group, 2018.
4. Chemaly RF, Heredia-Ariza EJ. Influenza and Parainfluenza Infection in Hematopoietic Stem Cell and Solid Organ Transplant Recipients. In: Transplant Infections. 4th. Springer, 2016.
5. Shah J, Chemaly RF. Herpes Simplex Virus Pneumonia in Patients with Hematologic Malignancies. In: Pulmonary Involvement in Patients with Hematologic Malignancies, First Edition: E. Azoulay (ed.) Springer-Verlag Berlin, Heidelberg, 2011.
6. Vigil K, Chemaly RF. CMV Pneumonia in Patients with Hematologic Malignancies. In: Pulmonary Involvement in Patients with Hematologic Malignancies, First Edition: E. Azoulay (ed.) Springer-Verlag Berlin, Heidelberg, 2011.
7. Chemaly RF, Rathod DB, Couch R. Viral Infections: Respiratory Viruses. In: Principles and Practices of Cancer Infectious Diseases. First Edition: A. Safdar (ed.) Humana Press, 2011.
8. Granwehr BP, Chemaly RF, Kontoyiannis DP. Fungal and Viral infections in cancer patients. In: Koller, Wolff and Kantarjian (eds). The MD Anderson Manual of Medical Oncology, 2011.
9. Ghantoji SS., Chemaly RF. Infections in Patients with Leukemia. In: Emerging Cancer Therapeutics. Demos Medical Publishing LLC, 411–428, 2011.
10. Perego C., Chemaly RF. Infection Control Procedures. In: Critical Care for Cancer Patients. Springer Publishing LLC, 2011.
11. Vigil K, Chemaly RF. Infectious Diseases: d) Viral Infections. In: Critical Care for Cancer Patients. Springer Publishing LLC, 2011.
12. Torres, HA, Boeckh M, Chemaly RF. Viral Infectious Diseases Issues. In: Internal Medicine Care of Cancer Patients. First Edition: Yeung SJ, Escalante C, and Gagel RF, eds. BC Decker Inc, 2008.
13. Bodey, GP, Chemaly RF, Kontoyiannis DP. Fungal and Viral infections in cancer patients. In: Koller, Wolff and Kantarjian (eds). The MD Anderson Manual of Medical Oncology. Mc-Graw-Hill Companies, Inc, 2006.
14. Torres HA, Chemaly RF. CMV Pneumonia. In: Encyclopedia of Molecular Mechanisms of Disease. Edited by Florian Lang, University of Tuebingen, Germany. Springer-Verlag, 2006.
15. Chemaly RF, Procop GW. Detection/Characterization of Fungal Pathogens. State-of-the art summary/critical review of literature. In: Molecular Microbiology: Diagnostic Principles and Practice, 2nd Edition. ASM press, 2003.

Books (edited and written)

1. Unknown. Infection Control and Prevention in Immunocompromised Hosts. Ed(s) Dr. Roy Chemaly, Amy Spallone, and Steve Pergam. Springer International Publishing AG, Switzerland.

Letters to the Editor

1. Coomes EA, Al-Shamsi HO, Meyers BM, Alhazzani W, Alhuraiji A, Chemaly RF, Almuhanna M, Wolff RA, Ibrahim NK, Chua MLK, Hotte SJ, Elfiki T, Curigliano G, Eng C, Grothey A, Xie C. In Reply. Oncologist 25: e1252-e1253, 2020.
2. Chemaly RF, Aitken SL, Wolfe CR, Jain R, Boeckh MJ. Aerosolized ribavirin: the most expensive drug for pneumonia. Transpl Infect Dis, 2016.
3. Chemaly RF, Ullmann AJ, Ehninger G. CMV prophylaxis in hematopoietic-cell transplantation. N Engl J Med, 2014.
4. Shah DP, Munsell MF, Chemaly RF. Ribavirin for upper respiratory tract infections. J Infect Dis, 2013.
5. Rolston KV, Mahajan SN, Chemaly RF. Antimicrobial de-escalation in cancer patients. Infection 40: 229-30, 2012.
6. Chemaly RF, Ghantoji SS, Stibich M. Novel Intervention for Eliminating VRE from the Environment. Arch Intern Med 171: 1684-1685, 2011.
7. Chemaly RF, Rathod DB, Raad II. A Tertiary Care Cancer Center Experience of the 2007 Outbreak of Serratia marcescens Bloodstream Infection Due to Prefilled Syringes. Infect Control Hosp Epidemiol 30: 1237-38, 2009.
8. Munsell M, Shah DP, Chemaly RF. Reply to Fatkenheuer et al. J Infect Dis.
9. Rolston KV, Nesher L, Mulanovich V, Chemaly R. Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies. Infection.
10. Chemaly RF, Clark TW. Viral therapeutics: where we are and where we are going. Curr Opin Infect Dis.
11. El Haddad L, Ariza-Heredia E, Chemaly RF. Response to Giménez et al. J Infect Dis.
12. Foolad F, Chemaly RF. Reply to the authors. Clin Infect Dis.